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Abstract 
There is growing evidence that older adults with type 2 diabetes exhibit deficits in 
executive function, the set of processes responsible for planning, organizing, 
sequencing, and monitoring goal-oriented behavior.  However, the specific nature of 
these executive impairments and their functional consequences in this population 
remain poorly understood.  The primary purpose of this work was to determine whether 
older adults with type 2 diabetes demonstrated impairments in the executive process of 
multi-tasking when compared to their peers without diabetes, and to examine how multi-
tasking abilities contributed to gait and other functional abilities in these individuals.  We 
also sought to examine the integrity of other executive functions in those with diabetes, 
including the processes responsible for updating information, shifting between different 
tasks, inhibiting predominant responses, and organizing and recalling visuospatial and 
verbal data, and to explore their relationships to gait and functional ability. 
Chapter 2 describes the results of our pilot investigation, in which we 
administered a measure of multi-tasking, the Cognitive Timed Up and Go (cTUG), and a 
battery of 7 common executive function tests to 20 adults (age 40-65 years) with 
diabetes and diabetic peripheral neuropathy (DPN) and 20 individuals of similar age 
without diabetes.  We found that those with DPN performed worse on the cTUG test, 
and also demonstrated poorer performance on executive function measures assessing 
visuospatial and verbal processing.  Moreover, we observed that overall cognitive 
performance and symptoms of depression were significantly related to each other and 
to a measure of functional ability, whereas signs and symptoms of DPN were not 
associated with this functional measure.  Although preliminary, this study illustrated the 
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potential relationships between neuropsychological and physical function, and 
highlighted that functional impairments, fall risk, and disability in those with DPN is likely 
the result of a complex and multi-factorial process that extends beyond somatosensory 
and proprioceptive impairment. 
Building upon the data and experience we obtained from this pilot project, we 
next selected two instruments, the Walking and Remembering and Pursuit Rotor tests, 
in an effort to describe multi-tasking in much greater detail than was possible with the 
cTUG alone.  As described in Chapter 3, these multi-tasking assessments, along with 
measures of single-task gait and self-reported functional ability and limitation, were 
administered to a group of 40 older adults (age 60 years and older) with type 2 diabetes 
and a group of 40 individuals without diabetes, pair-matched according to age, sex, 
education, and the presence or absence of hypertension.  Our analysis of this data 
revealed that those with diabetes performed worse than comparison subjects when 
asked to multi-task while walking, appearing to preserve less critical task demands at 
the expense of gait stability.  Interestingly, we observed little association between multi-
tasking ability and our gait and functional measures.  However, we did note rather 
striking relationships between these measures and symptoms of depression, physical 
activity level, and sleep quality.  Overall, this data suggested that older adults with type 
2 diabetes did exhibit disturbances that could impair safety when required to multi-task 
while walking.  Furthermore, although these changes did not appear to substantially 
influence single-task gait mechanics or self-reported functional ability, we also found 
that commonly overlooked variables such as depression, physical activity, and sleep 
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quality may make important contributions to everyday gait and function in this 
population. 
Examining these relationships in further detail, we next performed a series of 
regression analyses investigating the contributions of multi-tasking ability, depression, 
physical activity, and sleep quality to single-task gait speed and variability, and self-
reported physical function and disability in our group with diabetes.  Described in 
Chapter 4, this data demonstrated that there was little association between multi-tasking 
ability and single-task gait parameters or self-reported physical function and disability.  
However, our secondary analyses revealed significant adverse relationships between 
depression and gait variability and disability, between physical activity levels and 
walking speed and physical function, and between sleep quality and gait variability.  
Although often overlooked, factors such as depression, physical inactivity, and poor 
sleep quality are widespread in those with diabetes.  Our analysis emphasizes the 
importance of appropriately identifying and treating such modifiable comorbidities, as 
well as the need for further research examining their relationships to different aspects of 
physical function and disability.   
Having completed our examination of multi-tasking, we turned our attention to 
exploring the integrity of other executive functions in those with diabetes.  Alongside of 
our multi-tasking measures, we administered a battery of executive function tests 
assessing the processes of information updating, task shifting, response inhibition, and 
visuospatial and verbal processing and memory.  Analysis of this data revealed that 
those with diabetes appeared to perform more poorly than comparison subjects on a 
specific measure of updating and a measure of visuospatial processing.  However, we 
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did not observe deficits on a second updating measure, or on any other executive test.  
Interestingly, although there was little relationship between executive performance and 
gait or functional abilities in the diabetes group, we observed a number of significant 
correlations between updating, shifting, and visuospatial memory and gait and function 
in the comparison group.  These findings clearly emphasize the need for further 
research examining executive function in those with diabetes, and investigating how 
these processes contribute to physical deficits, falls, and/or disability in health and 
disease. 
In summary, the results of this body of work suggest that older adults with type 2 
diabetes demonstrate significant changes in gait stability when required to walk while 
multi-tasking, and may also exhibit deficits in areas of executive function related to the 
ability to update information and process visuospatial stimuli.  The influence of these 
and other executive functions on gait and functional ability remains unclear, but may 
differ between those with and without diabetes.  Certainly, it appears that factors such 
as depression, physical activity, and sleep quality make important contributions to 
everyday function.  Overall, our findings emphasize the need for further research 
investigating the physiological, psychological, and functional consequences of type 2 
diabetes in older adults, and the diverse factors that may contribute to the higher 
incidence of falls, functional deficits, or disability in this high risk patient population.  
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1.1 Abstract 
 The devastating impact of type 2 diabetes mellitus (DM) on vascular, renal, 
retinal, and peripheral nerve function is well documented.  However, there is also 
evidence that older adults with this disease exhibit impairments in the planning, 
coordinating, sequencing, and monitoring of cognitive operations, collectively known as 
executive function.  Although poorly understood, it is possible that disturbances in 
executive function, particularly those involved in the ability to multi-task, contribute to 
the gait abnormalities and increased risk for falls, functional impairments, and 
disabilities associated with type 2 DM.  Despite this, the relationships between 
executive function and functional abilities remain poorly understood in this population.   
This introductory chapter presents current neuropsychological research 
regarding the concept of executive function as a framework upon which to examine this 
highly functional cognitive entity in adults with type 2 DM.  The pathophysiological 
mechanisms thought to underlie diabetes-related executive dysfunction are also 
explored, as are the potential contributions of executive deficits to impairments in gait 
and function observed in the older population with type 2 DM.  The chapter concludes 
with a brief discussion of dual-task assessment and intervention strategies which may 
facilitate the care and rehabilitation of this growing patient population. 
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1.2 Overview 
 The public health threat posed by diabetes is unequivocal.  It is currently 
estimated that one out of every ten health care dollars spent in the United States is 
attributable to this disease (American Diabetes Association, 2008), and the incidence of 
type 2 DM, already among the most common major diseases in older adults, is 
projected to continue to rise due to an aging population, urbanization, and the 
increasing prevalence of obesity and physical inactivity (Wild, Roglic, Green, Sicree, & 
King, 2004).   
 Characterized by the improper utilization of insulin and resulting dysregulation of 
blood glucose levels, type 2 DM is associated with an array of debilitating clinical 
sequelae, including visual loss, renal dysfunction, wound formation, limb amputation, 
neuropathy, and cardio- and cerebrovascular disease (Nathan, 1993).  Alongside of 
these traditional complications, type 2 DM has also been identified as a significant risk 
factor for falls and disability (Gregg, Beckles, et al., 2000); as well as for cognitive 
impairment and dementia (Arvanitakis, Wilson, & Bennett, 2006).  
 While still poorly recognized, the impact of type 2 DM on cognition appears to 
extend across a broad range of functions (Kodl & Seaquist, 2008).  Of particular 
concern are deficits that have been observed in the set of high-level central processes 
responsible for planning, sequencing, organizing, and monitoring cognitive operations 
(Fontbonne, Berr, Ducimetiere, & Alperovitch, 2001; Okereke et al., 2008; Qiu et al., 
2006; Yeung, Fischer, & Dixon, 2009).  Collectively known as executive function, this 
cognitive entity has substantial functional implications.  As explained by Jurado and 
Rosselli (2007): 
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In a constantly changing environment, executive abilities allow us to shift our 
mind set quickly and adapt to diverse situations while at the same time inhibiting 
inappropriate behaviors.  They enable us to create a plan, initiate its execution, 
and persevere at the task at hand until its completion.  Executive functions 
mediate the ability to organize our thoughts in a goal-directed way and are 
therefore essential for success in school and work situations, as well as everyday 
living. (p. 214) 
Consistent with this, executive dysfunction has been linked to impairments in gait 
(Persad, Jones, Ashton-Miller, Alexander, & Giordani, 2008) and functional abilities 
(Pereira, Yassuda, Oliveira, & Forlenza, 2008); deficits which are more broadly 
implicated in falls (Anstey, von Sanden, & Luszcz, 2006), the loss of independence 
(Royall, Palmer, Chiodo, & Polk, 2004) and, ultimately, to institutionalization and 
mortality (Cesari et al., 2005).   
 Although growing evidence suggests that older adults with type 2 DM suffer from 
executive dysfunction, the complexities of both executive function and the diabetic 
disease process make interpretation of these deficits and their functional consequences 
difficult.  This has important implications for rehabilitation, as physical therapists and 
other rehabilitation providers are ideally positioned to identify and address such 
impairments before they can result in catastrophic functional loss.   
 
1.3 Executive Function: Concept and Processes 
 Despite extensive neuropsychological study, executive function remains 
notoriously resistant to formal definition.  Effectively first identified by Baddeley and 
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Hitch (1974) as the “central executive” responsible for overseeing working memory, 
executive function has evolved to more broadly describe a loosely defined set of control 
processes responsible for planning, coordinating, sequencing, and monitoring other 
cognitive operations (Hull, Martin, Beier, Lane, & Hamilton, 2008).  These processes 
enable the performance of goal-directed and future-oriented behavior (Suchy, 2009),  
with various authors placing highly functional cognitive activities ranging from attention 
and visuospatial processing to reasoning and planning under the auspices of executive 
function (Miyake, Friedman, et al., 2000).   
 Traditionally, the assessment and interpretation of executive abilities has been 
based on an assumption that performance on one or two measures reflects overall 
executive functioning (Miyake, Emerson, & Friedman, 2000).  However, the fact that 
executive functions must, by definition, express themselves through non-executive 
processes such as language, vision, or memory has brought such methodology into 
doubt, leading some neuropsychologists to caution that “a low score on a single 
executive test does not necessarily mean inefficient or impaired executive functioning” 
(Miyake, Emerson, et al., 2000).  Rather, they suggest that executive function may be 
more accurately described in terms of a number of related but dissociable processes.  
Table 1.1 illustrates these processes, and how they may relate to more complex 
cognitive activities, neuroanatomical areas, and clinical behaviors.  The processes 
relevant to our investigation, multi-tasking, updating, shifting, inhibition, and visuospatial 
function, are described in detail in the following sections.   
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Table 1.1:  Executive Processes and Their Relationships to Cognitive Abilities, 
Anatomical Structures, and Clinical Behaviors       
 
Executive 
Processes 
 
Cognitive  
Ability 
 
Anatomical 
Correlate  
 
Clinical 
Presentation 
 
•  Multi-tasking 
 
•  Updating 
 
•  Sequencing 
 
 
 
•  Planning 
 
•  Reasoning 
 
 
•  Dorsolateral pre- 
   frontal cortex 
 
 
•  Disorganization 
 
•  Sequencing 
 
•  Updating 
 
•  Shifting 
 
•  Initiation 
 
•  Multi-tasking 
 
•  Visuospatial  
   Function 
 
 
 
 
 
 
 
•  Organization 
 
 
 
 
 
 
 
•  Superomedial pre- 
   frontal cortex  
 
 
 
 
 
 
•  Apathy 
 
•  Updating 
 
•  Inhibition 
 
 
 
•  Judgment 
 
 
 
 
•  Ventromedial and  
   orbitofrontal cortex 
 
 
•  Disinhibition 
 
•  Multi-tasking 
 
•  Shifting 
 
•  Updating 
 
•  Visuospatial  
   Function 
 
 
 
 
 
•  Problem Solving 
 
 
 
 
 
•  Dorsolateral pre- 
   frontal cortex 
 
 
 
 
•  Perseveration 
Adapted from Suchy (2009) 
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1.3.1 Dividing Attention (“Multi-tasking”)   
 Associated with prefrontal cortical activity (D'Esposito et al., 1995; Wagner & 
Smith, 2003), the ability to time share or “multi-task” in order to perform simultaneous 
activities is traditionally identified as an executive function due to Baddeley and Hitch’s 
(1974) widely influential model of working memory, which consists of a central executive 
mechanism responsible for the supervision of subordinate “slave” systems.  According 
to this model, the concurrent performance of a primary cognitive task and a secondary 
task tapping a slave system will disrupt performance of the primary task from its 
baseline, or single-task level, presumably due to an insufficient executive capacity to 
share attention between the competing demands of the two tasks (Hegarty, Shah, & 
Miyake, 2000).  These “dual-task costs” can be easily calculated via the following 
formula: 
                                    (Dual-task Performance – Single-task Performance)    
      |Dual-task Cost| =  Single-task Performance                          X 100 
 
This value represents a percent difference between single- and dual-task conditions (for 
example, a 5% decline in walking speed) and allows for comparison across individuals, 
groups, or time (K. McCulloch, 2007).  It is important to note that dual-task costs can be 
either positive or negative.  Conventionally, a decline in task performance under dual-
task conditions is denoted as a positive dual-task cost, while an improvement in 
performance under dual-task conditions is represented by a negative dual-task cost. 
 Several factors figure in the interpretation of such dual-task costs as reflections 
of executive function.  First, the type and difficulty of the tasks must be carefully 
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considered.  For example, if a participant is asked to simultaneously perform two tasks 
which require visual input, such as a visual discrimination task and a walking task which 
involves visually locating obstacles, interference will likely occur within the visual system 
and performance on one or both tasks will deteriorate.  Similarly, very simple or familiar 
tasks may be well within the participant’s attentional capacity and thus fail to elicit dual-
task costs; whereas tasks involving mathematical computation or complex language 
skills may be more difficult for those with limited education (K. McCulloch, 2007), and 
thus distort the degree to which executive abilities are represented. 
 Additionally, researchers have observed that subjects will typically allocate more 
attention to the task perceived to be the most challenging, regardless of whether it is 
designated as primary or secondary (Hegarty et al., 2000).  This “strategic tradeoff” may 
result in a small dual-task cost for the primary task at the expense of secondary task 
performance.  Task prioritization can be influenced by task demands, instructions, and 
participant goals, and is particularly relevant to assessments involving gait and balance 
activities, as these tasks may be prioritized as a means of maintaining safety (Hegarty 
et al., 2000; K. McCulloch, 2007).  In order to account for these strategic tradeoffs, both 
the primary and secondary tasks must be monitored for dual-task costs (Hegarty et al., 
2000) and many researchers have found it advantageous to abandon the designation of 
primary and secondary tasks altogether (K. McCulloch, 2007).  Table 1.2 provides 
several examples of clinical measures that are commonly used to assess multi-tasking 
ability, including the Walking and Remembering Test, which is employed in our 
investigation. 
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1.3.2 Updating and Monitoring Information (“Updating”) 
  Closely related to working memory, the executive function described as 
“updating” provides a means by which external information can be utilized to update 
internal representations in order to effectively respond to changing environmental 
demands (Salthouse, Atkinson, & Berish, 2003).  To accomplish this, incoming 
information is monitored and processed for relevance to an active task, and then 
employed to update older, irrelevant information held in the working memory with 
newer, more relevant information (Miyake, Friedman, et al., 2000).    
The crucial distinction between updating and working memory is that updating 
involves the active manipulation of data within the working memory, as opposed to the 
passive storage of task-relevant information (Miyake, Friedman, et al., 2000).  This 
distinction has been supported by neuroimaging studies indicating that the passive 
storage and maintenance of working memory are linked to activity in the premotor 
frontal cortex and parietal lobes, whereas active updating is associated with the 
dorsolateral prefrontal cortex (Jonides & Smith, 1997; Stuss et al., 2002). 
 
1.3.3 Mental Set and Task Shifting (“Shifting”) 
 Alternatively referred to as attention switching or cognitive flexibility, the 
executive function known as “shifting” is considered to be responsible for the ability to 
transfer attention back and forth between multiple operations, tasks, or mental sets 
(Monsell, 1996).  Extending beyond the spatial switching of visual attention via voluntary 
eye movement, the process of shifting involves disengagement from an irrelevant task 
set with the subsequent engagement of a more relevant task set (Miyake, Friedman, et 
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al., 2000).  Recent evidence indicates that the shifting function may also, or perhaps 
instead, reflect the ability to override the interference or negative priming generated by a 
previously performed task in order to perform a different cognitive operation (Allport & 
Wylie, 2000).   
 A prominent feature of frontal lobe damage, repeated perseveration on an 
inappropriate response is commonly interpreted as a deficit in the ability to shift mental 
sets, and neuropsychological and neurophysiological studies have implicated frontal, as 
well as occipital and parietal areas, in this process (Miyake, Friedman, et al., 2000; 
Stuss et al., 2002). 
  
1.3.4 Response Inhibition 
 The executive function known as “inhibition” represents a process described by 
Logan (1994) as an “internally generated act of control” which enables the deliberate 
suppression of a prepotent, or automatic, response when desired (Miyake, Friedman, et 
al., 2000; Salthouse et al., 2003).  This provides an important and highly adaptive 
means by which dependence on habit and familiarity may be overcome; as well as a 
mechanism by which responses already in preparation may be suppressed (Salthouse 
et al., 2003).   
 Conceptually distinct from the involuntary decrease in activation levels often used 
to describe neural networks, this controlled and deliberate executive process has been 
closely linked to activation of the prefrontal cortex (Stuss et al., 2002), and deficits in 
inhibition are frequently associated with frontal lobe damage or dysfunction (Jahanshahi 
et al., 1998; Kiefer, Marzinzik, Weisbrod, Scherg, & Spitzer, 1998).  
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1.3.5 Visuospatial Function 
 Responsible for perception of the surrounding world in two and three dimensional 
space, visuospatial functions encompass the encoding of visual information, 
maintenance of visual imagery, and manipulation of this data within memory.  Broadly, 
these abilities are mediated by separate pathways responsible for perception and action 
(Goodale & Milner, 1992).  The ventral stream, traveling through the occipitotemporal 
cortex to the ventrolateral prefrontal cortex, is traditionally characterized as the “What” 
pathway.  The dorsal stream, traversing the occipitoparietal cortex to the dorsolateral 
prefrontal cortex, appears to mediate spatial perception (“Where”) and visually guided 
action (“How”) pathways (Tankus & Fried, 2012). 
 The unconscious translation of this information from a retinal image into an 
internal construction of the perceived world is fundamentally cognitive, described by 
Hoffman (1998) as an intelligent process in which retinal images are used to develop 
internal representations that are tested and updated as the perceiver scans and 
interacts with the environment.   In particular, neuropsychological evidence indicates 
that visuospatial problems requiring complex, multi-step solutions heavily involve 
executive function (Kuo et al., 2005).  Table 1.3 provides examples of measures 
commonly used to assess visuospatial function and the other executive functions 
described above. 
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1.4 Executive Function and Type 2 Diabetes Mellitus   
 Although there is no clear consensus as to the impact of type 2 DM on executive 
function in older individuals, there does appear to be good cause for concern.  Indeed, 
impaired performance on a variety of executive tasks has been reported in older adults 
with type 2 DM (de Wet, Levitt, & Tipping, 2007; Munshi et al., 2006; Qiu et al., 2006; 
Thabit et al., 2009; van den Berg et al.; Yeung et al., 2009), while a significantly greater 
risk of executive decline has also been observed in longitudinal investigations of type 2 
DM and cognition (Fontbonne et al., 2001; Kuo et al., 2005; Okereke et al., 2008; van 
den Berg et al.).    
 Perhaps the strongest evidence of diabetes-related executive dysfunction stems 
from Yeung et al.’s (2009) analysis of a multi-dimensional executive battery 
administered to 465 older adult subjects, of whom 41 suffered from type 2 DM.  Those 
with diabetes scored approximately 12% and 14% worse than their non-diabetic peers 
on executive measures of inhibition and shifting, respectively.  This detrimental effect of 
diabetes on executive function remained significant even after the sample was divided 
into young-old (53-70 years) and old-old (71-90 years) groups, suggesting that these 
impairments were more likely mediated by diabetic status than by age. 
  Others have also reported indications of executive dysfunction in samples of 
older adults with type 2 DM.  One group, for instance, examined the cognitive profiles of 
291 homebound individuals over the age of 60, finding that those with type 2 DM 
(n=115) demonstrated significant deficits of approximately 7%, 17%, and 21% on 
executive measures of updating/working memory, visuospatial function, and shifting, 
respectively (Qiu et al., 2006).  These findings are broadly consistent with longitudinal 
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data describing small but significant baseline deficits of up to 10% on measures of 
attention and shifting in older adults with type 2 DM (Fontbonne et al., 2001; Gregg, 
Yaffe, et al., 2000).  These individuals also suffered nearly a two-fold greater risk of 
decline on these measures over 4- and 6-year periods. 
 It is important to note, however, that associations between type 2 DM and 
executive dysfunction have not been uniformly demonstrated.  For example, a sample 
of 1,917 elderly individuals (n=218 with type 2 DM) revealed no significant executive 
impairments on a composite measure of updating and inhibition tasks (Saczynski et al., 
2008).  Likewise, Ruis et al. (2009) noted no impairments on a series of unspecified 
executive tasks in a sample of 183 older subjects with recently diagnosed type 2 DM.  
These results corroborate literature reviews describing only inconsistent relationships 
between type 2 DM and executive dysfunction (Awad, Gagnon, & Messier, 2004; 
Messier, 2005). 
 
1.5 Pathophysiological Mechanisms of Executive Dysfunction in Diabetes   
 Despite somewhat conflicting clinical evidence, physiological data appears to 
reinforce the likelihood of executive dysfunction in older adults with type 2 DM; 
potentially due to neuroanatomical changes resulting from impaired glycemic control, 
vascular disease, and insulin resistance (Figure 1.1).  While there is empirical support 
for each of these mechanisms, the etiological pathways underlying diabetes-related 
cognitive and executive impairments likely result from a multi-factorial process including 
these and other factors (Kodl & Seaquist, 2008).         
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Figure 1.1: Potential Mechanisms of Executive Dysfunction in Diabetes 
 
 
 
Adapted from Kodl and Seaquist (2006) 
17 
 
1.5.1 Neuroanatomical Changes    
 Among the notable findings of structural abnormalities associated with diabetes 
are magnetic resonance imaging observations of diffuse brain atrophy and white matter 
lesions in individuals with type 2 DM (Manschot et al., 2006; Schmidt et al., 2004).  For 
example, Manshot et al.’s (2006) study of 164 older adults revealed that those with type 
2 DM (n=113) exhibited as much as 23% more cortical atrophy, 12% more subcortical 
atrophy, and significantly more deep white matter lesions and infarcts than control 
subjects.  Interestingly, this study also observed small to moderate (effect size=0.2-0.4), 
statistically significant deficits in attention, processing speed, and memory in these 
individuals.  
 Other MRI investigations have also demonstrated that those with type 2 DM 
exhibit periventricular, amygdalar, and hippocampal atrophy similar to that observed in 
Alzheimer’s disease (den Heijer et al., 2003).  Moreover, a recent functional magnetic 
resonance imaging (fMRI) study conducted by Zhou et al. (2010) revealed reduced 
functional connectivity between the hippocampus and frontal and temporal cortical 
structures in a sample of elderly adults with type 2 DM when compared to a group 
without diabetes.  While these findings were not directly associated with deficits in 
executive performance, subjects with diabetes were noted to perform significantly worse 
on a measure of executive function than their counterparts without diabetes. 
 
1.5.2 Role of Glycemic Control  
  The hallmark feature of diabetes, impaired glycemic control has long been 
suspected to contribute to the development of diabetes-related cognitive dysfunction 
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(Kodl & Seaquist, 2008).  Supporting this are studies describing significant inverse 
relationships between glycosylated hemoglobin (HbA1c) and measures of working 
memory (r=-0.37) and visuospatial function (r=-0.38) (Munshi et al., 2006).  However, 
other studies have contradicted these findings, demonstrating no association between 
hyperglycemia and cognitive function; as well as between repeated episodes of 
hypoglycemia and cognitive function (Lindeman et al., 2001; Scott, Kritz-Silverstein, 
Barrett-Connor, & Wiederholt, 1998).  
 Theories as to how hyperglycemia may mediate cognitive dysfunction are largely 
centered around observations that, in animal models of diabetes, hyperglycemia results 
in the formation of advanced glycation end products (AGEs) and reactive oxygen 
species (ROSs), activation of polyol and protein kinase C pathways, increased glucose 
shunting in the hexosamine pathway, and alterations in neurotransmitter function 
(Biessels, van der Heide, Kamal, Bleys, & Gispen, 2002; Klein & Waxman, 2003).  Such 
changes may ultimately lead to neuronal damage; however further research is 
necessary to determine which, if any, of these mechanisms contribute to cognitive 
impairments and/or executive dysfunction in humans with diabetes (Kodl & Seaquist, 
2008). 
 
1.5.3 Role of Vascular Disease   
 Diabetes is known to be associated with a greater risk of cardio- and 
cerebrovascular disease (Nathan, 1993), and it has been suggested that vascular 
dysfunction may contribute to executive disturbance (Kodl & Seaquist, 2008).  This is 
consistent with findings that the interaction of diabetes and hypertension is related to 
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cortical brain atrophy (Schmidt et al., 2004) and may confer as much as a two-fold 
greater risk of dementia (Whitmer, Sidney, Selby, Johnston, & Yaffe, 2005).  In addition, 
neuro- and angiopathic changes have been observed in the cranial nerves and spinal 
cord of the diabetic nervous system (Kodl & Seaquist, 2008). 
 While the mechanisms through which vascular dysfunction may mediate 
neurological abnormalities in diabetes remain unknown, there is speculation that 
reduced cerebral blood flow combined with the activation of the thromboxane A2 
receptor, which has also been noted in diabetes (Biessels et al., 2002), may result in 
inadequate vasodilation of the cerebral vasculature and an increased likelihood of 
ischemia (Kodl & Seaquist, 2008).   
 There is also evidence that the coupling of ischemia and hyperglycemia may 
provide an environment in which agents such as lactate (McCall, 1992) and/or 
glutamate (Li et al., 2000), can accumulate in the brain and exacerbate neurological 
injury.  Despite some preliminary data supporting this theory, the extent to which 
vascular mechanisms may contribute to diabetes-related executive dysfunction or to 
broader cognitive impairments remains unclear.    
 
1.5.4 Role of Insulin Resistance   
 Originally thought to be insulin-independent, it is now known that insulin plays an 
important neurotrophic role within the brain (Craft & Watson, 2004), easily crossing the 
blood-brain barrier (Banks, Jaspan, Huang, & Kastin, 1997; Banks, Jaspan, & Kastin, 
1997) and interacting with widely distributed receptors in many brain regions (Craft & 
Watson, 2004).  These regions include areas that are critical to cognitive and behavioral 
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function, such as the cerebral and frontal cortices, hippocampus, basal ganglia, 
substantia nigra, hypothalamus, septum, and amygdala (Marks, Porte, Stahl, & Baskin, 
1990; Unger et al., 1989).  
 The relationship between insulin resistance and cognitive dysfunction is 
particularly interesting in light of findings suggesting that the incidence of Alzheimer’s 
disease is elevated in individuals with type 2 DM and insulin resistance (Cukierman-
Yaffe et al., 2009; Kuusisto et al., 1997; Luchsinger et al., 2007; Ott et al., 1999), and 
vice versa (Janson et al., 2004).  It is unclear whether this relationship arises directly 
from the effects of insulin or insulin resistance on neural tissues, or from the impact of 
poor metabolic control.  However, there is some evidence that those with Alzheimer’s 
disease and normal glycemic levels secrete a greater amount of insulin than control 
subjects when provided with oral glucose, indicating an increased degree of insulin 
resistance (Bucht, Adolfsson, Lithner, & Winblad, 1983; Fujisawa, Sasaki, & Akiyama, 
1991). 
 The means by which insulin resistance may contribute to executive and cognitive 
dysfunction remain a matter of much speculation.  Some researchers, noting 
correlations between inflammatory markers and both type 2 DM and Alzheimer’s 
disease, have proposed the existence of as-yet-unknown common pathophysiological 
pathways between insulin resistance, inflammation, and Alzheimer’s disease (Hak et al., 
2001; Yaffe, Blackwell, Whitmer, Krueger, & Barrett Connor, 2006).  Others (Lee et al., 
1999; Tojo et al., 1996) have observed upregulation of the hypothalamic-pituitary-
adrenal axis, and it has been speculated that disruption of this neurological pathway 
may result in elevated serum cortisol levels that have been linked to impairments in 
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cognitive processes such as attention, reasoning, concept formation and memory 
(Forget, Lacroix, Somma, & Cohen, 2000; Lupien et al., 1994).   
 Although still controversial, it has also been suggested that insulin resistance 
may promote development of the amyloid beta plaques characteristic of Alzheimer’s 
disease; possibly by increasing the deposition and/or inhibiting the degradation of this 
protein (Kodl & Seaquist, 2008).  Similarities have been noted between the deposition of 
islet amyloid in the pancreatic islets of individuals with type 2 DM and the deposition of 
amyloid beta in Alzheimer’s disease, suggested that a common pathological mechanism 
may underlie these findings (Craig, Weissman, & Horwich, 1994).  Interestingly, the 
association between type 2 DM and Alzheimer’s disease may hinge, in part, on the 
presence or absence of the apolipoprotein (APOE) allele ε4.  Although there is evidence 
suggesting that insulin-resistance poses a significant risk factor for Alzheimer’s disease 
only in those individuals without this allele (Kuusisto et al., 1997), some research has 
contradicted this finding (Peila, Rodriguez, & Launer, 2002). 
 
1.6 Executive Function, Diabetes, and Gait  
 Ambulation is one of the most complex human functions, involving the integration 
of input from numerous sensory and motor sources with carefully controlled, repetitive 
motor movements.  When intact, this system produces the highly efficient and 
consistent pattern that is a characteristic of stable gait.  When disrupted, however, 
whether through the process of normal aging or through pathology, the resulting loss of 
stability results in fluctuations in both temporal and spatial parameters (Hausdorff, 
2007).  These changes are of considerable concern due to their association with falls, a 
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major source of mortality, injury, and mobility restriction among older adults (Tinetti & 
Williams, 1997).  Such concerns are magnified within the diabetic population, as these 
individuals have been shown to be at a higher risk for falls (Gregg, Beckles, et al., 2000) 
and report a higher incidence of fall-related injuries (Miller, Lui, Perry, Kaiser, & Morley, 
1999; Wallace et al., 2002) than those without diabetes.  
 Among the gait parameters most strongly linked to negative outcomes such as 
falls are alterations in gait velocity and variability (Cesari et al., 2005; Hausdorff, 2007).  
More commonly utilized, gait velocity provides a quick, reliable, and easily administered 
clinical assessment, and a well-established means of predicting major health-related 
outcomes (Cesari et al., 2005).  Specifically, slower self-selected gait velocities, 
particularly below the level of 1 m/s, have been linked to falls, persistent lower extremity 
limitation, hospitalization, and death (Cesari et al., 2005; Harada et al., 1995). 
 Even more powerfully related to fall risk, however, are stride to stride fluctuations 
in gait across time, commonly referred to as gait variability (Hausdorff, 2005).  When 
conceptualized as inconsistencies in the neuromuscular ability to maintain and regulate 
a steady gait sequence, it is not surprising that increasing variability in features such as 
stride length, width, and/or time are associated with increasing instability and a risk for 
falls (Hausdorff, 2005).  Consistent with this, increased gait variability is associated with 
increased fall risk, with one group observing that an increase in stride length variability 
of as little as 0.017 m doubled the risk for falls over the following 6-months in 
community-dwelling older adults (Maki, 1997).   
 Although cognitive function was once thought to exert little influence on walking 
ability; however, the neuropsychological factors underlying gait are now increasingly 
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recognized.  This is likely due to a growing appreciation for the fact that locomotion 
requires not only the generation and control of motor commands, but also an awareness 
of purpose and ability to process multiple incoming stimuli in order to adapt to dynamic 
environments (Yogev-Seligmann, Hausdorff, & Giladi, 2008).  The integration, 
sequencing, and monitoring of these various cognitive, motor, and behavioral demands 
is often attributed to executive function (Lord, Rochester, Hetherington, Allcock, & Burn, 
2009).  Indeed, a number of studies have indicated that individuals with executive 
deficits walk slower (Ble et al., 2005; Pettersson, Olsson, & Wahlund, 2007; Sheridan, 
Solomont, Kowall, & Hausdorff, 2003), demonstrate increased stride variability 
(Hausdorff, Yogev, Springer, Simon, & Giladi, 2005; Sheridan et al., 2003), and fall 
more frequently than those with intact executive abilities (Shumway-Cook et al., 2000; 
Shumway-Cook, Woollacott, Kerns, & Baldwin, 1997).  
 As with individuals suffering from executive dysfunction, those with diabetes have 
been shown to exhibit abnormal gait characteristics (Mueller, Minor, Sahrmann, Schaaf, 
& Strube, 1994; Petrofsky, Lee, & Bweir, 2005), likely contributing to the higher risk of 
falls experienced by this population (Gregg, Beckles, et al., 2000).  Highlighting these 
findings in a recent review of 28 high to moderate quality studies encompassing 772 
individuals with diabetes, Allet et al. (2008) identified broad agreement that individuals 
with diabetes walked more slowly, with greater stride variability, and increased plantar 
pressures than those without diabetes.  This review also described evidence suggesting 
the existence of abnormalities in kinematic, kinetic, and muscle activation parameters in 
these individuals. 
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 While the gait deviations observed in older adults with diabetes resemble those 
associated with executive dysfunction, these abnormalities are most frequently 
attributed to diabetic peripheral neuropathy.  However, there is evidence that individuals 
with diabetes but no evidence of neuropathy walk at speeds as much as 48% slower 
that of non-diabetic individuals, with a significantly wider stance, and with increased 
lower extremity flexion/extension and lateral joint movements, or “errors”.  These joint 
errors appear to be due, in part, to tremors occurring at frequencies implicating a central 
neurological origin (Petrofsky et al., 2005).  Moreover, Brach et al. (2008) found that 
those with diabetes (n=119) ambulated at speeds 8% slower than non-diabetics, with an 
8% shorter step length, 14% wider and 4% longer stance, and 6% longer double 
support time.  Each of these differences was statistically significant, as was the amount 
(approximately 6%) of the association between diabetes and walking speed explained 
by executive tasks assessing attention and shifting.  When combined with a global 
cognitive task and a measure of depression, these measures attenuated the 
relationship between diabetes and gait speed by over 50% after controlling for age, sex, 
and race.  
Furthermore, it appears that the gait abnormalities associated with diabetes 
could be exacerbated in situations requiring higher levels of executive involvement, 
such as those involving multi-tasking between simultaneous tasks.  For example, Paul 
et al. (2009) found that performing a serial mental subtraction task or carrying a tray of 
water-filled cups while walking significantly slowed gait speed by up to 27% in 15 older 
adults with diabetes and no signs of peripheral neuropathy.  In addition, these tasks 
decreased step length by up to 20% and increased double support time by as much as 
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17%.  That these changes were not significantly different from those elicited in a similar 
group with diabetic peripheral neuropathy would seem to emphasize a central limitation 
in the executive ability needed to divide attention between the tasks, rather than a 
peripheral limitation in the somatosensory pathways affected by diabetic neuropathy.   
 
1.7 Executive Function, Diabetes, and Functional Abilities 
 It is clear that severe damage to brain areas implicated in executive functioning 
can produce impairments across a wide spectrum of functional abilities.  However, even 
subtle disturbances that occur in the absence of overt neurological damage are of 
significant concern, as they are powerful predictors of functional loss (Cahn-Weiner, 
Malloy, Boyle, Marran, & Salloway, 2000).  Although very few studies have investigated 
whether executive dysfunction may contribute to the disproportionately large degree of 
physical impairment and disability known to exist within the elderly diabetic population, 
there is some evidence that this may be the case.   
 For example, Kuo et al. (2007) analyzed measures of cognition, physical 
function, and activity of daily living (ADL) status in 2,802 community-dwelling older 
adults (n=358 with diabetes), revealing a significantly greater rate of decline in 
performance on an executive measure of attention in subjects with diabetes.  This was 
matched by a significantly increased rate of decline in performance on the physical 
function component of the Short-Form-36 Health Survey and a measure of ADL function 
assessing meal preparation, housework, financial and health care management, phone 
use, shopping, and traveling.   
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 These findings appear to be largely consistent with those reported in a sample of 
homebound individuals aged 60 and older (Qiu et al., 2006).  Indeed, this study noted 
that subjects with type 2 DM exhibited significant impairments of up to 21% in executive 
tasks of shifting, working memory, and visuospatial function; as well as a 10% reduction 
in ADL function on a measure assessing walking, eating, dressing, bathing, toileting, 
and food preparation.  While the authors reported that these poorer ADL scores were 
related to the observed executive deficits, this was not elaborated upon. 
 
1.8 Clinical Implications 
As keen observers of both cognitive and physical functioning, rehabilitation 
providers are ideally positioned to recognize and address cognitive-motor impairments 
such as those that appear to be associated with type 2 DM.  Given the enormous 
prevalence of this disease in the elderly population and the known consequences of 
executive dysfunction in terms of falls and functional limitations, this may have critical 
implications – especially as multi-disciplinary input from neuropsychology, speech-
language pathology, and other such disciplines is not always readily available.   
While a number of instruments are available for assessing executive function and 
its component processes, it seems that the most clinically relevant of these, from a 
physical therapy and rehabilitation standpoint, are dual-task assessments of multi-
tasking ability (Table 1.3).  Although such dual-task assessments have yet to achieve 
widespread use in diabetic populations, the bulk of evidence appears to suggest that 
these measures can provide valuable objective data regarding an individual’s executive 
ability to safely coordinate and perform simultaneous tasks.  In particular, the Walking 
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and Remembering Test described by McCulloch et al. (2009) addresses many of the 
limitations generally associated with dual-task assessment (K. McCulloch, 2007).  
Further research and collaboration with the neuropsychological community will be 
necessary to establish the validity and reliability of such tasks for older adults with 
diabetes.  However, it seems likely that the use of these tools will enhance recognition 
of cognitive-motor deficits in this population, and may help identify patients at risk for 
falls and other functional impairments.              
In addition to facilitating clinical assessment, the executive process of multi-
tasking appears to be an attractive target for intervention strategies aimed at improving 
functional and/or cognitive ability.  Indeed, preliminary evidence indicates that dual-task 
training interventions may beneficially impact function.  Silsupadol et al. (2009), for 
example, found that a randomized and controlled 4-week training intervention 
combining balance activities with number recall and animal naming tasks improved 
dual-task gait speed by as much 0.18 m/s (effect size 0.46-0.57) in older adults with 
balance impairments.  Similar results have also been reported in randomized, controlled 
studies examining dual-task interventions in older adults with dementia (Schwenk, 
Zieschang, Oster, & Hauer, 2010).  Notably, the lack of significant improvements in 
dual-task abilities observed in the control groups of these studies indicate that single-
task training alone may not improve dual-task ability.  As dual-task activities often more 
closely mimic normal function than do single-task activities, therapists may be well 
advised to consider incorporating such activities into their treatment plans.    
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1.9 Conclusions 
While it is difficult to fully elucidate their impact, it seems likely that disease-
related changes in executive function adversely affect functional abilities in older adults 
with type 2 DM.  Physical therapists and other rehabilitation providers should be 
prepared to recognize possible impairments in executive function in older patients with 
diabetes, and understand that these changes may directly or indirectly influence even 
the most basic daily activities.   
Although not commonly applied in populations with DM, executive assessments 
involving dual-task performance appear to represent a promising means of both 
assessment and treatment.  Through close collaboration with the neuropsychological 
community, future research should establish the validity, predictive ability, efficacy, and 
generalizability of such strategies.  Ultimately this will allow a clearer picture of diabetes-
related executive and cognitive impairment to emerge, facilitating the development of 
clinical tools that may be employed to detect and address the devastating 
consequences of this disease. 
 
1.10 Specific Aims and Hypotheses of this Work 
As illustrated in this chapter, the integrity and influence of multi-tasking and other 
executive functions in older adults with type 2 diabetes remains poorly understood.  The 
purpose of this body of work is to determine whether executive processes, particularly 
those involved in multi-tasking, are impaired in older adults with type 2 DM, and to 
examine how these processes may contribute to functional abilities.    
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Specific Aim 1:  To determine whether the executive domain of multi-tasking is impaired 
in older adults with type 2 DM.   Impairments in the ability to multi-task have been 
observed in older adults, as well as in individuals suffering from a broad range of 
disorders associated with executive dysfunction.  Although some evidence suggests 
that individuals with type 2 DM also exhibit deficits in the multi-tasking, much of this 
research suffers from substantial methodological limitations.  We hypothesize that older 
adults with type 2 DM will demonstrate impaired multi-tasking, as evidenced by 
increased dual-task costs associated with the performance of the Walking and 
Remembering Test (Hypothesis 1) and a Pursuit Rotor test (Hypothesis 2), when 
compared to those without diabetes. 
 
Specific Aim 2:  To examine the relationship between the executive domain of multi-
tasking and measures of functional ability in older adults with type 2 DM.  Despite 
apparent links between multi-tasking and the ability to perform functional activities, such 
as gait and activities of daily living, the extent to which multi-tasking contributes to these 
functional abilities in individuals with type 2 DM remains largely unknown.  We 
hypothesize that a measure of multi-tasking, the grand dual-task cost associated with 
the Walking and Remembering Test and Pursuit Rotor test, will serve as a significant 
predictor of criterion measures of gait velocity (Hypothesis 3), stride time variability 
(Hypothesis 4), physical functioning (Hypothesis 5) and disability (Hypothesis 6), 
obtained from quantitative gait analysis and the Late Life Function and Disability Index, 
in older adults with type 2 DM. 
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Specific Aim 3:  To explore whether other domains of executive function and cognition 
are impaired in older adults with type 2 DM, and how these domains may relate to 
functional ability in this population.  In addition to multi-tasking, there are indications that 
older adults with type 2 DM may also exhibit impairments in domains of executive 
function such as updating, shifting, and inhibition; as well as in executive and cognitive 
operations such as perceptual and visuospatial organization and memory and logical 
memory.  Due to limitations in the measures used to assess this population, however, 
the nature of diabetes-related dysfunction with regard to these processes remains 
unclear, as do their potential contributions to functional abilities.  In this exploratory aim 
we will collect data on these executive and cognitive domains in order to examine their 
integrity in older adults with type 2 DM, as well as their associations with physical 
function and disability. 
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Chapter 2 Preface 
As described in Chapter 1, individuals with diabetes appear to be susceptible to 
disturbances in executive function that may adversely affect functional abilities.  Chapter 
2 details our first attempt to examine multi-tasking and executive function in this 
population, and explore its relationship to physical function.  Through collaboration with 
a larger study of fall risk in people with diabetic peripheral neuropathy, led by Stephen 
Jernigan PT, PhD, we administered a measure of multi-tasking, the Cognitive Timed Up 
and Go test, and a small battery of common tests of executive function to a total of 20 
subjects.   
The initial comparison of these results to normative values reported in the 
literature proved very interesting; our subjects appeared to perform poorly on the 
Cognitive Timed Up and Go and in areas of verbal and visuospatial function.  Armed 
with this data, we received institutional approval to administer our multi-tasking and 
executive assessment battery to a group of 20 non-diabetic individuals of similar age.   
The comparison of this group to our sample of individuals with diabetic peripheral 
neuropathy comprises Chapter 2.         
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Chapter 2 
 
 
 
 
 
 
 
 
 
Pilot Study of Multi-tasking and Executive Function in Adults with Diabetic Peripheral 
Neuropathy 
 
 
 
 
 
 
 
 
Rucker JL, Jernigan, SD, McDowd JM, and Kluding PM. Adults with Diabetic Peripheral 
Neuropathy Exhibit Deficits in Multi-tasking and Other Executive Functions. Journal of 
Neurologic Physical Therapy. 2014; (38)2: xx-xx (in press). 
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2.1 Abstract 
BACKGROUND AND PURPOSE:  Diabetic peripheral neuropathy (DPN) contributes to 
functional impairment, and there is growing evidence that neuropsychological factors 
also influence physical function.  We compared cognitive and executive function in 
adults with DPN to an age-matched comparison group, and examined the relationships 
between DPN, executive function, and physical function.  METHODS: Twenty subjects 
with DPN and 20 comparison subjects were assessed.  DPN was quantified via the 
Michigan Neuropathy Screening Instrument and nerve conduction velocity testing.  
Subjects were administered Beck’s Depression Inventory, the Mini Mental Status 
Examination, and the Timed Up and Go test (TUG).  Each subject also completed a 
battery of 7 executive function tasks, including the Cognitive Timed Up and Go test 
(cTUG), in which a concurrent mental subtraction task was added to the standard TUG 
test.  RESULTS:  The DPN group had poorer global cognitive scores and reported more 
symptoms of depression.  This group also performed worse on executive measures of 
verbal fluency and visuospatial function, and took longer to complete both the TUG and 
cTUG.  Poorer global cognitive performance and greater depression symptoms were 
significantly related to each other and to slower TUG times.  DISCUSSION AND 
CONCLUSIONS:  Verbal, visuospatial, and multi-tasking measures of executive 
function may be impaired in adults with DPN.  Future research should examine how 
these and other cognitive and psychological factors, such as depression, affect physical 
function in this population.  
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2.2 Introduction 
Current estimates suggest that diabetes affects at least 25.8 million individuals in the 
United States and, with aging, will likely affect over one-quarter of the adult population 
(Centers for Disease Control and Prevention [CDC], 2011).  Of the many complications 
related to diabetes, diabetic peripheral neuropathy (DPN) is among the most common, 
occurring in up to 60% of adult patients (CDC, 2011).  Resulting from peripheral nerve 
degeneration and impaired neural regeneration, DPN typically manifests as symmetrical 
pain and/or loss of sensation in the distal extremities (Sinnreich, Taylor, & Dyck, 2005).  
This is of substantial concern, as DPN is associated with impaired balance, gait 
abnormalities, and an increased risk for lower extremity amputation (Mueller, Minor, 
Sahrmann, Schaaf, & Strube, 1994; Thurman, Stevens, & Rao, 2008). 
             While its destructive effects on peripheral nerve function are well established, 
there is also evidence that diabetes damages central nervous system structures 
underlying important cognitive functions (Kodl & Seaquist, 2008).  In particular, adults 
with diabetes appear to demonstrate deficits in executive function; the broadly defined 
set of processes responsible for planning, coordinating, sequencing, and monitoring 
cognitive operations (de Wet, Levitt, & Tipping, 2007; Manschot et al., 2006; Qiu et al., 
2006; Yeung, Fischer, & Dixon, 2009).  Such diabetes-related executive impairments 
are especially interesting in light of studies highlighting the complex interplay between 
cognitive processes and functional motor skills.   
Much of the research related to the association between cognitive and motor 
functions centers on the ability to multi-task in order to perform simultaneous activities.  
However, other executive processes, such as attention, task shifting, working memory, 
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verbal fluency and organization, and visuospatial organization, may also link cognitive 
and physical function.  Several investigations have found that executive function 
contributes to gait in individuals with diabetes.  Brach et al. (2008) examined walking 
speed in a sample of 558 older adults, finding it to be significantly slower in those with 
diabetes.  Interestingly, scores on the Trail Making Test, a common measure of 
executive function, explained a greater portion of this relationship than lower extremity 
vibratory perception, a measure of DPN.  Likewise, executive measures involving dual-
task performance (e.g. walking while performing serial mental subtraction) have been 
shown to impair gait in individuals with diabetes, both with and without DPN (Paul, Ellis, 
Leese, McFadyen, & McMurray, 2009; Roman de Mettelinge et al., 2013). 
 Although it is clear that DPN contributes to the elevated fall risk and functional 
impairments experienced by those with diabetes, almost nothing is known about 
executive abilities in those with DPN and how these factors interact to influence physical 
function. The purpose of this study was to examine whether adults with DPN exhibited 
changes suggestive of executive dysfunction, and to explore the relationships between 
measures of neuropsychological function, peripheral neuropathy, and functional ability. 
 
2.3 Methods 
2.3.1 Study Design and Sample 
This cross-sectional study was conducted in collaboration with a larger 
investigation of fall risk assessment in individuals with DPN.  Institutional approval for 
both studies was granted by the human subjects committee of the University of Kansas 
Medical Center. 
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   A total of 20 individuals with DPN and 20 individuals without diabetes (ages 40-
65 years) were recruited for the study.  Diagnosis of DPN was confirmed via 
administration of the Michigan Neuropathy Screening Instrument (MNSI) and nerve 
conduction studies of the tibial and peroneal nerves. If screening and/or nerve 
conduction testing raised questions about the presence of DPN, a collaborating 
neurologist was consulted to determine the presence or absence of the condition.  
Exclusion criteria included the following:  1) major medical depression, 2) musculo-
skeletal problems limiting ambulation, 3) open wounds on the feet, 4) inability to 
ambulate independently, 5) uncorrectable visual deficits, 6) central nervous system 
pathology or dementia, and 7) untreated vestibular disorder and/or postural 
hypotension.  
 
2.3.2 Procedures 
After signing an institutionally-approved consent form, data regarding age, 
height, and weight were recorded for each subject.  Those with DPN were then 
administered the MNSI, and glycosylated hemoglobin (HbA1c) and nerve conduction 
testing were completed.  Finally, all subjects completed measures assessing depression 
symptoms and global cognitive function, followed by the TUG, cTUG, and a battery of 
executive function tests administered in a standardized order.  All cognitive testing was 
conducted by the same investigator in a quiet laboratory setting to minimize distraction.  
Nerve conduction assessment was conducted by a research technician in the 
Department of Neurology at the University of Kansas Medical Center.  
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2.3.3 Measures 
The following assessments were obtained from subjects with DPN: 
1) The Michigan Neuropathy Screening Instrument (MNSI) symptom questionnaire 
was used to assess self-reported symptoms of DPN via yes/no response to 15 
items, reflecting the frequency and severity of neuropathic symptoms.  A higher 
score on a scale of 0-13 indicated greater neuropathic symptoms ().    
2) The MNSI physical exam score was used to assess foot appearance, vibration 
sense, reflexes, and monofilament sensation.  A score of 2 or more on a scale of 
0-10 suggested the presence of peripheral neuropathy (Feldman, Russell, 
Sullivan, & Golovoy, 1999).  
3) Nerve conduction studies were used to assess nerve conduction velocity, 
amplitude, and latency of the right lower extremity peroneal and tibial nerves. 
 
The following assessments were obtained from all subjects in both the DPN and 
comparison groups: 
1) Beck’s Depression Inventory-II was used to quantify self-reported symptoms of 
depression.  This measure is scored on a 21-item, 63-point scale, with scores of 
19 or less indicating minimal symptoms of depression, 20-28 moderate 
symptoms, and ≥ 29 severe symptoms (Beck, Steer, & Brown, 1996).  
2) The Mini-Mental Status Examination (MMSE) was used to assess global 
cognitive function.  This 30-point instrument broadly reflected orientation, 
memory, concentration, and praxis, with scores of < 24 indicating severe 
cognitive impairment (Folstein, Folstein, & McHugh, 1975). 
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3) The Timed Up and Go test (TUG) was used to assess functional mobility 
(Shumway-Cook, Brauer, & Woollacott, 2000).  Subjects stood from a chair and 
walked 3 m, turned, returned to the chair, and sat down.  The TUG was 
performed twice, and the average time in seconds recorded.  This value also 
represented single-task walking time for analyses of multi-tasking ability.     
4) The Cognitive Timed Up and Go Test (cTUG) was used to assess multi-tasking 
during functional mobility (Shumway-Cook et al., 2000).  Subjects performed the 
standard TUG with a simultaneous cognitive task in which they serially 
subtracted 3’s from a random number between 80 and 100.  The cTUG was 
performed twice, and the average time to complete the walking task and the rate 
of correctly reported digits per second of walking time were recorded.  A single-
task trial of the cognitive task was then performed while the subject was seated.  
The time allowed for this single-task cognitive trial was equivalent to the subject’s 
average cTUG time.   
5) The Rey Osterrieth Complex Figure was used to assess visuospatial 
organization.  Subjects were given a copy of an asymmetrical geometric figure 
and asked to draw the figure as accurately as possible without the use of a 
straight edge.  Each drawing was scored by the same examiner on a 
standardized 36-point scale, with higher scores indicating greater accuracy 
(Lezak, Howieson, Loring, Hannay, & Fischer, 2004). 
6) Letter and Category Fluency were used to assess verbal fluency and 
organization (Lezak et al., 2004).  Subjects were given a letter of the alphabet (F, 
A, S) or category (animals, vegetables, articles of clothing) and allowed 1 minute 
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to verbally provide as many words as possible (excluding proper nouns) 
beginning with that letter or falling within that category.  The total number of 
words provided for the 3 letters and 3 categories represented letter fluency and 
category fluency, respectively. 
7) Forward and reverse digit span were used to assess attention and working 
memory, respectively (Lezak et al., 2004).  Subjects were read a series of digits 
and asked to immediately repeat the digits back in the same order, or in reverse 
order.  The number of correctly reported digits, ranging from 0-8 (forward) and 0-
7 (reverse), was recorded. 
8) The Trail Making Test was used to assess task shifting ability (Homack, Lee, & 
Riccio, 2005).  In part A of the test, subjects drew a line connecting series of 
letters or numbers in order as quickly as possible (e.g. A-B-C; 1-2-3 etc).  In part 
B of the test subjects drew a line connecting numbers and letters in an 
alternating fashion (e.g. 1-A-2-B etc.).  A percent difference score between the 
two conditions was calculated by taking the difference between the times 
required to complete parts A and B, divided by the time required to complete part 
A. 
 
2.3.4 Statistical Analysis 
 Data analysis was conducted using SPSS 16.0 for Windows (Chicago, IL).  In 
order to examine multi-tasking performance on the cTUG a percent change, or dual-
task cost, from the single-task condition to the dual-task condition was calculated for 
both walking time and rate of cognitive task performance via the following formula:     
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|Dual-task Cost| = (Dual-task performance – Single-task performance)      x 100 
                                                      Single-task performance 
Data distribution was examined via scatterplot, and descriptive statistics calculated for 
each measure.  Between-group mean differences were assessed with 2-tailed 
independent t-tests, and within-group changes from single- to dual-task conditions 
assessed with 2-tailed paired t-tests.  Pearson-product-moment correlations examined 
the relationships between variables.  An alpha level of 0.05 was used to assess the 
significance of all findings. 
 
2.4 Results 
2.4.1 Sample Characteristics 
 General characteristics of the two groups are illustrated in Table 2.1.  Twenty 
people with DPN (8 female; age 58.4±6.2 years) and 20 people without diabetes (14 
female; age 54.9±6.1 years) participated in the study.  Differences in age between the 
two groups were not significant (p=0.08).  Glycemic control in those with DPN was 
impaired (HbA1c 7.2±1.4%; range 5.6-11.0).  Subjects with DPN demonstrated greater 
BMI (37.0±8.4 vs. 24.8±4.1 kg/m2, p<0.001); as well as higher levels of depression 
(Beck’s Depression Inventory 11.3±6.5 vs. 1.6±1.8, p<0.001) and lower global cognitive 
scores (MMSE 27.8±2.0 vs. 29.5±0.8, p=0.001). 
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Table 2.1:  Subject Characteristics 
 DPN  
(n=20) 
Comparison  
(n=20) 
P-value 
Age 58.4 ± 6.2 54.9 ± 6.1 0.080 
Sex 8 female 14 female NA 
BMI 37.0 ± 8.4* 24.8 ± 4.1 < 0.001 
BDI 11.3 ± 6.5* 1.6 ± 1.8 < 0.001 
MMSE 27.8 ± 2.0* 29.5 ± 0.8 0.001 
HbA1c 7.2 ± 1.4 NA NA 
Table 2.1:  Data are presented as mean ± SD.  Abbreviations: DPN, diabetic peripheral neuropathy; BMI, 
body mass index; BDI, Beck’s Depression Inventory; MMSE, Mini-Mental Status Examination; NA, not 
applicable.  *Significant between-group difference at p<0.05. 
 
2.4.2 Peripheral Neuropathy Measures 
 The results of DPN screening and tibial and peroneal nerve conduction testing 
are provided in Table 2.2.  One subject declined to undergo nerve conduction testing.  
In the remaining sample of 19 subjects, MNSI-subjective (mean score 3.1±2.0), MNSI-
physical (mean score 5.9±2.6), and nerve conduction measures (peroneal nerve 
conduction velocity 40.9±5.1 m/s; tibial nerve conduction velocity 38.9±4.3 m/s) were 
consistent with the presence of neuropathy. 
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Table 2.2:  Results of Peripheral Neuropathy and Executive Assessments 
 DPN  Comparison  P-value 
MNSI – subjective  (score out of 13) 3.1 ± 2.0 NA NA 
MNSI – physical (score out of 10) 5.9 ± 2.6 NA NA 
Peroneal nerve conduction velocity (m/s) 40.9 ± 5.1 NA NA 
Tibial nerve conduction velocity (m/s) 38.9 ± 4.3 NA NA 
Rey-Osterrieth Complex Figure (score out 
of 36) 
25.9 ± 4.3* 31.7 ± 2.4 < 0.001 
Letter fluency (words) 34.2 ± 11.6* 46.2 ± 12.2 0.003 
Category fluency (words) 47.0 ± 8.1* 56.3 ± 8.5 0.001 
Forward digit span (digits) 10.1 ± 1.9 10.5 ± 2.6 0.535 
Reverse digit span (digits) 6.3 ± 2.3 6.0 ± 1.9 0.655 
Trail Making Test Change (% difference) 32.1 ± 43.0 12.7 ± 21.0 0.077 
Table 2.2:  Data are presented as mean ± SD.  Peroneal and tibial nerve conduction velocity was 
assessed in 19 subjects.  Abbreviations: DPN, diabetic peripheral neuropathy; MNSI, Michigan 
Neuropathy Screening Instrument; NA, not applicable.  *Significant between-group difference at p<0.05. 
 
2.4.3 Timed Up and Go Performance 
 The results of the TUG are illustrated in Figure 2.1.  On average, the DPN group 
required more time to complete the TUG than the comparison group (10.3±2.8 vs. 
5.9±1.0 seconds, p<0.001). 
 
2.4.4 Cognitive Timed Up and Go Performance 
 The results of the cTUG are illustrated in Figures 2.1 and 2.2.  Those with DPN 
required more time to complete the cTUG than comparison subjects (13.0±5.8 vs. 
60 
 
6.9±1.6 seconds, p<0.001).  The added cognitive task slowed walking time in both the 
DPN (+2.7±3.4 seconds, p=0.002) and comparison groups (+1.0±0.9 seconds, 
p<0.001).  However, percent changes from single- to dual-task conditions (e.g. dual-
task cost) for walking speed were not different between the groups (p=0.45).   
 The rate at which subjects performed the cognitive task also declined under dual-
task conditions in both groups (DPN: -0.12±0.12 digits/second, p<0.001; CN: -0.17±0.22 
digits/second, p=0.003).  However, there were no between-group differences in either 
single- or dual-task cognitive performance (p=0.11 and 0.14, respectively) or in the dual-
task cost for the cognitive task (p=0.53). 
 
Figure 2.1: Timed Up and Go and Cognitive Timed Up and Go Walking Speed  
 
Figure 2.1:  Timed Up and Go (TUG; white 
bars) and Cognitive Timed Up and Go 
tests (cTUG; black bars) walking speed.  
The cTUG test involved the addition of a 
simultaneous cognitive task to the standard 
TUG test.  *Significant between-group 
difference at p<0.05.  ǂSignificant within-
group difference at p<0.05.     
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Figure 2.2: Single- and Dual-task Cognitive Performance 
Figure 2.2: Cognitive task performance under single- 
(white bars) and dual-task conditions (black bars).  
Under single-task conditions, subjects serially 
subtracted 3’s from a random number between 80 and 
100 while seated.  Under dual-task conditions, subjects 
completed the same cognitive task while 
simultaneously performing the TUG test (e.g. the 
cTUG).  The time allowed for the cognitive task under 
single- and dual-task conditions was equivalent.  
ǂSignificant within-group difference at p<0.05.  
In order to explore whether subjects with DPN prioritized the two cTUG tasks 
differently than comparison subjects, we examined the patterns of individual dual-task 
costs for the walking and cognitive tasks (Figure 2.3).  This was done by plotting each 
subject’s single-task performance against their dual-task performance for both walking 
speed (A) and rate of cognitive task performance (B).  The distance the point fell from a 
line representing no change in performance from single- to dual-task conditions (e.g. a 
dual-task cost of 0%) reflected the dual-task cost for that particular task.    
 This analysis revealed that comparison subjects exhibited an average dual-task 
cost in walking speed of 17.0±14.6%, with a similar but more variable cost to the 
cognitive task of 17.5±28.5%.  In contrast, subjects with DPN exhibited large and highly 
variable dual-task costs in both walking speed and cognitive task performance 
(22.1±26.1 and 23.0±26.7%, respectively). 
 
ǂ 
ǂ 
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2.4.5 Executive Function Measures 
 The results of the remaining executive function measures are provided in Table 
2.2.  The DPN group performed worse on the Rey Osterrieth Complex Figure (25.9±4.3 
vs. 31.7±2.4 points, p<0.001) and measures of letter (34.2±11.6 vs. 46.2±12.2 words, 
p=0.003) and category fluency (47.0±8.1 vs. 56.3±8.5 words, p=0.001).  No between-
group differences were observed on forward digit span (p=0.535), reverse digit span 
(p=0.655), or Trail Making Test (p=0.077). 
 
2.4.6 Relationships between Neuropsychological Function, DPN Measures, and TUG 
Performance 
  For 19 subjects with DPN, relationships between age, BMI, HbA1c, depression, 
signs and symptoms of DPN, and neuropsychological function were examined using 
Pearson-product moment correlation coefficients.  Selected correlations from this data 
are presented in Table 2.3.  Surprisingly, older age was associated with a lower MNSI 
physical score (r=-0.57, p=0.009), and higher scores on this instrument (e.g. more signs 
of DPN) were associated with better category fluency scores (r=0.45, p=0.05).   
 No other measure of DPN was significantly related to any neuropsychological 
test or to the TUG.  Of the remaining variables only depression, BMI, and MMSE scores 
were associated with cognitive function or TUG performance.  Greater symptoms of 
depression were related to poorer performance on the MMSE (r=-0.46, p=0.04) and 
TUG (r=0.54, p=0.02), while poorer MMSE score was related to slower TUG time      
(r=-0.53, p=0.02).  Paradoxically, higher BMI was associated with a better score on the 
Rey Osterrieth Complex Figure test (r=0.47, p=0.04). 
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Table 2.3: Correlations between Measures of Neuropsychological Function, Nerve 
Function, and the TUG Test in Subjects with DPN  
 MMSE ROCF LF CF TUG 
BDI -0.46* -0.03 0.12 0.20 0.54* 
MNSI-S -0.25 -0.03 -0.25 0.22 0.19 
MNSI-P 0.14 0.30 0.06 0.45 -0.07 
PNCV -0.09 -0.25 0.03 -0.02 0.04 
TNCV 0.17 -0.15 -0.04 0.03 -0.25 
TUG -0.53* -0.19 -0.28 -0.08 -- 
Table 2.3: Abbreviations: BMI, body mass index; BDI, Beck’s Depression Inventory; MNSI-S, Michigan 
Neuropathy Screening Instrument – subjective; MNSI-P, Michigan Neuropathy Screening Instrument – 
physical; PNCV, peroneal nerve conduction velocity; TNCV, tibial nerve conduction velocity; TUG, Timed 
Up and Go; MMSE, Mini-Mental Status Examination; ROCF, Rey-Osterrieth Complex Figure; LF, Letter 
fluency; CF, Category fluency.  *Significant at p<0.05.    
 
2.5 Discussion 
Our study provides preliminary evidence suggesting that individuals with DPN 
exhibit disturbances in aspects of executive function.  Other researchers have reported 
similar findings of neuropsychological dysfunction in those with diabetes.  For example, 
Yeung et al. (2009) reported that older adults with type 2 diabetes performed 
significantly worse on several executive measures than those without diabetes.  
Notably, these differences persisted after dividing the subjects into young-old (53-70 
years) and old-old (71-90 years) sub-groups, suggesting that the deficits were due to 
diabetic status rather than age.  Likewise, Thabit et al. (2009) found that nearly half of 
their sample of 50 older adults with type 2 diabetes demonstrated significant executive 
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impairments, particularly in verbal fluency, on a standardized measure of executive 
function.   
 While our data are broadly consistent with such studies, it is important to note 
that we did not establish the educational level of our subjects.  It is possible that some 
of the deficits we observed, particularly with regard to verbal fluency, reflect differences 
in education between the groups.  However, we also observed differences on a 
measure less likely to be influenced by educational level.  Specifically, we found that 
those with DPN performed significantly worse on the Rey Osterrieth Complex Figure, an 
untimed test of visuospatial organization in which the subject simply copies an 
asymmetrical geometric figure and is scored according to the accuracy of their 
reproduction. 
 Although our neuropsychological findings are interesting, their impact on 
everyday function remains unclear.  We did not observe relationships between 
measures of executive function and the TUG; however others have reported that poor 
performance on executive measures containing visuospatial and verbal executive 
components negatively influences diabetes care (Munshi et al., 2006) and disease self-
management (Thabit et al., 2009).  Further research is clearly needed to examine 
whether visuospatial, verbal, and/or other measures of executive function can be 
specifically linked to functional outcomes such as gait or ADL performance in this and 
other populations. 
 Our analysis of TUG performance revealed that the DPN group walked 
significantly slower than the comparison group.  They also took longer to complete the 
walking portion of the cTUG, with the added cognitive task slowing walking speed by 
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22%.  This is consistent with reported declines of 25% and 22% under similar dual-task 
walking conditions in subjects with diabetes with and without DPN, respectively (Paul et 
al., 2009); although the “dual-task cost” in walking speed for our subjects with DPN was 
not statistically greater than the 17% decline we observed in comparison subjects. 
 In comparison to published literature, the average cTUG time for our comparison 
group (6.9 seconds) was well below the average TUG time reported by Bohannon 
(2006) for individuals aged 60-69 years (8.1 seconds).  In contrast, the average cTUG 
time for those in the DPN group (13.0 seconds) was comparable to the reported 
average TUG time of individuals aged 80-99 years (Bohannon, 2006).  The average 
cTUG time for those in the DPN group also exceeded the fall risk cut-off score of 12 
seconds proposed for community-dwelling adults aged 65-85 years (Bischoff et al., 
2003).  The fact that the mean age of our DPN sample was only 58 appears to highlight 
the potential functional implications of multi-tasking in this population. 
 One possible explanation for the decline in cTUG walking performance is that 
subjects focused their attention on the cognitive task at the expense of walking speed.  
This does not appear to have been the case in our study, as cognitive task performance 
also declined significantly in both groups; although the 26% decline in cognitive 
performance exhibited by the DPN group was not statistically different than the 19% 
decline observed in the comparison group.      
 The fact that we did not observe differences in the dual-task costs of walking or 
cognitive performance between the groups may result from the large degree of 
variability elicited by these tasks.  This may have occurred because, while we instructed 
subjects to “walk as quickly and safely as possible,” we did not explicitly instruct them to 
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prioritize either the walking or cognitive task during the cTUG.  The substantially greater 
degree of variability in cognitive versus walking task performance exhibited by 
comparison subjects suggests that this group more often opted to sacrifice cognitive 
task performance in order to protect walking speed.  This was in rather stark contrast to 
those in the DPN group, who seemed unable to consistently protect either task.  We 
observed that subjects who performed worst on the TUG appeared least likely to protect 
walking performance under the dual-task conditions of the cTUG.  This was particularly 
notable in the DPN group and is alarming, as it indicates that individuals already at risk 
for falling may fail to self-protect walking and/or balance when multi-tasking – potentially 
placing them at even greater fall risk.     
 In order to more clearly characterize multi-tasking performance, future research 
may benefit from dual-task measures that do not require mathematical ability and 
account for both gait speed and stability, such as the Walking and Remembering Test 
(McCulloch & Marshall, 2004).  Likewise, studies that directly influence and/or 
manipulate task priority may improve understanding of how attention is allocated under 
dual-task conditions and help explain whether and/or why different populations fail to 
protect function and safety while multi-tasking. 
 Because little research has explored the relationships between central and 
peripheral nervous system function in those with DPN, and it is unclear how these 
measures may be associated with functional ability in this population, we explored the 
correlations among measures of neuropsychological function, DPN, and the TUG.  
Interestingly this analysis indicated that depression and cognitive function were 
associated with each other, and were the only variables significantly related to slower 
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TUG performance.  This is consistent with other studies that have linked depression to 
cognitive dysfunction in those with diabetes (Bruce, Casey, & Grange, 2003) and 
associated both factors with gait (Brach et al., 2008) and functional deficits 
(Ciechanowski, Katon, & Russo, 2000).   
 Despite the fact that the prevalence of depression in those with diabetes is nearly 
twice as high as the non-diabetic population (Ali, Stone, Peters, Davies, & Khunti, 2006) 
these relationships remain largely unrecognized.  This is perhaps because conventional 
wisdom suggests that somatosensory and proprioceptive deficits resulting from DPN 
are the primary mediators of functional impairments.  Although exploratory, our findings 
suggest that the factors underlying fall risk and disability in those with DPN are much 
more numerous, diverse, and subtle than traditionally thought.  
 Our analysis also indicated an association between higher BMI and better 
visuospatial performance on the Rey Osterrieth Complex Figure.  Although counter-
intuitive, there is a large body of recent evidence supporting a so-called “obesity 
paradox,” in which obesity and/or higher BMI provide some degree of protective benefit 
in terms of cognitive functions, including attention and visuospatial function (Gunstad, 
Lhotsky, Wendell, Ferrucci, & Zonderman, 2010), and lower the risk of mortality in those 
with diabetes (Carnethon, Chavez, & Biggs, 2012; Kokkinos et al., 2012; Doehner, 
Erdmann, & Cairns, 2012).  Clearly, no conclusions on such matters can be drawn from 
our small sample.  However, our findings join those of others in cautioning that the 
factors positively and/or negatively influencing cognitive function in complex diseases 
such as diabetes may not be as straightforward as conventional wisdom would suggest.  
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We acknowledge that there are a number of factors limiting interpretation of our 
data.  In addition to the small sample size, first and foremost is the fact that we did not 
establish the education level of our subjects.  This factor undoubtedly may have 
influenced performance on some cognitive measures, particularly those involving verbal 
fluency and/or mathematical ability.  However, we also observed deficits in measures, 
such as the Rey Osterrieth Complex Figure, that would not seem to be heavily 
influenced by education, and the fact that the groups did not perform differently on the 
mathematical component of the cTUG suggests that education level may not have 
substantially influenced this measure.  Differences in variables such as sex, duration of 
diabetes, and the presence and number of other comorbidities may have also 
influenced our results.   
 Another limitation, inherent to our study, is the difficulty in assessing complex 
cognitive abilities such as executive function.  This is a topic of much debate within the 
neuropsychological community, and a standardized approach has yet to be determined 
(Miyake, Emerson, & Friedman, 2000).  Our assessment battery is consistent with 
current recommendations that executive function be analyzed via multiple measures 
assessing specific aspects of the executive construct; as opposed to simply relying on 
one or two measures to globally represent executive function.     
 Finally, we performed multiple correlations to explore the relationships between 
demographic factors, measures of neuropsychological function and DPN, and the TUG.  
Due to the small size and novel nature of our investigation, we did not correct for these 
multiple analyses.  While this unquestionably limits our interpretation, the significant 
correlation coefficients we observed were relatively strong and provide interesting 
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avenues for further research.  The findings of our study should be regarded with 
caution, and certainly causal relationships cannot be inferred between any of the 
variables we examined.  It is not clear that differences in cognitive function resulted 
directly from diabetes or depression.  Nor can it be said that cognitive deficits, 
depression, or any other variable caused gait dysfunction.  However, we feel that our 
data do emphasize the complex and multi-factorial relationships between 
neuropsychological and physiological factors and physical function in those with 
diabetes and DPN. 
 
2.6 Conclusions 
 Our investigation suggests that adults with DPN exhibit disturbances in 
visuospatial and verbal aspects of executive function.  Further, our data support the 
view that gait dysfunction, fall risk, and disability in those with diabetes may not be 
solely a consequence of DPN and/or musculoskeletal impairment.  It is critical that 
clinicians recognize the potential influence of cognitive and psychological function on 
physical abilities in patients with DPN so that gait dysfunction, fall risk, and disability can 
be effectively identified and treated in this high risk patient population. 
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Chapter 3 Preface 
Our preliminary investigation of executive function in individuals with diabetes 
revealed possible executive deficits in multi-tasking, verbal fluency, and visuospatial 
organization.  Although these findings were quite interesting, our ability to interpret this 
data was hampered by a number of substantial methodological limitations.  In order to 
address these limitations, we first turned our attention to conducting a more detailed 
analysis of what we felt was likely the most functionally relevant of these executive 
processes – the ability to multi-task.  We also chose to shift our focus to the segment of 
the diabetic population commonly identified as being at highest risk for both cognitive 
and functional decline – older adults with type 2 diabetes.   
We first identified two instruments, the Walking and Remembering and Pursuit 
Rotor Tests, that would allow us to describe multi-tasking much more robustly then the 
Cognitive Timed Up and Go alone.  These assessments, in addition to spatiotemporal 
measures of single-task gait and self-reported functional ability and limitation, were 
administered to 40 individuals with diabetes aged 60 and older, as well as a comparison 
group of 40 non-diabetic individuals paired according to age, sex, educational level, and 
the presence or absence of hypertension.  The analysis of multi-tasking performance 
between these two groups, and our exploration of the relationships between these 
abilities and measures of gait and function, comprises Chapter 3.        
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Chapter 3 
 
 
 
 
 
 
 
 
 
Multi-tasking in Older Adults with Type 2 Diabetes Mellitus 
 
 
 
 
 
 
 
 
 
 
A version of this chapter is in preparation for submission to Physical Therapy: the 
Journal of the American Physical Therapy Association (2014) 
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3.1 Abstract  
BACKGROUND AND PURPOSE: Deficits in the ability to multi-task contribute to gait 
abnormalities and falls in many at-risk populations.  However, it is unclear whether older 
adults with type 2 diabetes mellitus (DM) also demonstrate impairments in multi-
tasking.  We examined multi-tasking performance in older adults with DM and explored 
its relationship to measures of gait and functional ability.  METHODS: Forty individuals 
with type 2 DM were compared to a matched group of 40 individuals without 
diabetes.  Multi-tasking was examined during ambulation via the Walking and 
Remembering Test (WART), and while seated via the Pursuit Rotor Test (PRT).  Self-
selected normal and fast walking speed and stride length variability were measured 
using a GaitMat II System, and self-reported functional ability assessed via the Late Life 
Function and Disability Index (LLFDI).  RESULTS: Subjects with DM were slower and 
more unstable when multi-tasking while walking, and performed worse overall on the 
WART than comparison subjects.  This group was also walked more slowly under 
normal and fast conditions, demonstrated greater variability under fast conditions, and 
reported lower levels of physical function on the LLFDI.  Measures of multi-tasking 
demonstrated little correlation with gait and functional ability in either group; however 
symptoms of depression, physical activity level, and sleep quality were significantly 
associated with these measures in both groups.  DISCUSSION AND 
CONCLUSIONS: Older adults with DM appear to exhibit disturbances that may impair 
safety when required to multi-task while walking.  Further research should explore 
whether these and other neuropsychological and health factors influence safety, falls, 
and function in this high risk patient population. 
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3.2 Introduction 
 The ability to divide attention between simultaneous activities in order to multi-
task is among the most essential behaviors for human function.  This intricate balancing 
of attentional resources is often attributed to executive function (Miyake, Emerson, & 
Friedman, 2000) and is best elicited via dual-task paradigms that examine disruptions in 
performance that typically occur when multiple tasks are undertaken simultaneously 
(McCulloch, 2007).  Such dual-task studies suggest that an impaired ability to multi-task 
may influence gait and function in a number of high risk groups (Haggard, Cockburn, 
Cock, Fordham, & Wade, 2000; Sheridan, Solomont, Kowall, & Hausdorff, 2003; Yogev 
et al., 2005), including one of the fastest growing segments of the American population 
– the older adult with diabetes (Paul, Ellis, Leese, McFadyen, & McMurray, 2009; 
Roman de Mettelinge et al., 2013)  
 Characterized by impairments in insulin production and utilization and the 
resulting dysregulation of glucose levels, diabetes currently affects an estimated 25.8 
million individuals, including fully one-quarter of all older adults (Centers for Disease 
Control and Prevention [CDC], 2011).  Type 2 diabetes accounts for up to 95% of this 
number (CDC, 2011) and, frighteningly, is projected to afflict 1 in every 3 Americans by 
the year 2050 (Boyle et al., 2001). 
 There is no question that type 2 diabetes can devastate the peripheral nervous 
system (Sinnreich, Taylor, & Dyck, 2005).  However, it also appears to have important 
consequences for the central nervous system, including neuroanatomical changes in 
cortical areas linked to aspects of neuropsychiatric and executive functions (Kodl & 
Seaquist, 2008).  At present the degree to which neuropsychological disturbances 
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influence gait and physical function in older individuals with diabetes remains largely 
unknown.  In many cases, these functional deficits are attributed nearly exclusively to 
diabetic peripheral neuropathy.  However, gait abnormalities have been observed in 
individuals with diabetes but no evidence of neuropathy (Petrofsky, Lee, & Bweir, 2005; 
Yavuzer, Yetkin, Toruner, Koca, & Bolukbasi, 2006), and several groups have reported 
that depression and cognitive function may be as much related to gait and function as 
signs and symptoms of neuropathy (Brach, Talkowski, Strotmeyer, & Newman, 2008; 
Rucker, Jernigan, McDowd, & Kluding, in press) 
Also of substantive interest is evidence that walking while performing a cognitive 
task significantly disrupts gait speed and kinematics in individuals with diabetes, both 
with and without peripheral neuropathy, when compared to those without diabetes.  
That these changes do not appear to differ greatly between those with and without 
neuropathy seems to suggest a primary limitation in the executive ability required to 
divide attention between the tasks, rather than in peripheral somatosensory function 
(Paul et al., 2009; Roman de Mettelinge et al., 2013) 
Despite this preliminary evidence, few studies have examined multi-tasking in 
older adults with diabetes, or explored whether this contributes to the widespread 
incidence of falls and functional deficits observed in this population.  We hypothesized 
that subjects with type 2 diabetes would demonstrate impaired performance on two 
measures of multi-tasking, the Walking and Remembering and Pursuit Rotor Tests, 
when compared to a group of non-diabetic subjects matched for age, sex, education, 
and hypertension status.  Our secondary hypothesis was that multi-tasking performance 
in subjects with diabetes would be significantly correlated with quantitative measures of 
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gait speed and variability, and with self-reported measures of physical function and 
disability.      
 
3.3 METHODS 
3.3.1 Study Design and Sample 
 Institutional approval for this cross-sectional study was granted by the Human 
Subjects Committee of the University of Kansas Medical Center.   
 A total of 40 individuals aged 60 years and older with a medical diagnosis of type 
2 diabetes and 40 similarly aged individuals without diabetes were recruited.  Each 
subject with diabetes (DM) was matched to a comparison subject (CN) in terms of age 
(± 5 years), sex, highest level of education completed (high school vs. college), and the 
presence or absence of hypertension.  This yielded a total sample of 40 matched pairs.  
Subjects were provided with a $50 stipend upon completing the study.  Exclusion 
criteria included the following:  1) known history of central nervous system pathology, 2) 
musculoskeletal or orthopedic conditions significantly affecting gait and/or balance, 3) 
inability to ambulate without an assistive device, 4) self-reported body mass index of > 
45 kg/m2, 5) uncorrectable visual/auditory deficits or color blindness, 6) wounds on the 
weight bearing surfaces of the feet, 7) less than a high school level of education, and/or 
8) cognitive impairment as evidenced by a score of ≥ 2 on the AD8 Dementia Screening 
Interview or a score of < 26 on the Mini-Mental Status Examination.       
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3.3.2 Procedures   
 Following telephone screening and the signature of an institutionally-approved 
informed consent form, data regarding age, height, weight, medical comorbidities, 
current medications, and number of falls in the past 6 months were gathered.  A fasting 
blood glucose measurement was then obtained from each subject (Contour Blood 
Glucose Monitoring System, Bayer, Tarrytown, NY), and glycosylated hemoglobin 
(HbA1c) levels measured for each subject with diabetes via disposable finger-stick kits 
(Metrika A1CNow+, Bayer, Tarrytown, NY).  Potential comparison subjects exhibiting 
fasting blood glucose levels ≥ 126 mg/dL were excluded from participation and referred 
to a physician for further metabolic evaluation.  A small snack was made available to 
each subject once fasting blood glucose level was established.  All study participants 
were tested in a normoglycemic state, defined as a blood glucose level of between 80 
and 250 mg/dL. 
 After glycemic testing, each subject was administered a series of questionnaires 
assessing symptoms of depression, physical activity level, sleep quality, and functional 
ability.  This was followed by two randomly ordered measures of multi-tasking, the 
Walking and Remembering and Pursuit Rotor Tests, and quantitative analysis of gait 
speed and variability.  All testing was conducted by the same research personnel in a 
quiet laboratory setting to minimize distraction. 
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3.3.3 Measures 
 Multi-tasking Assessments 
1) The Walking and Remembering Test (WART, Figure 3.1A) is a clinical measure 
of multi-tasking ability involving the individual (e.g. single-task) and simultaneous 
(e.g. multi-task) performance of ambulatory and cognitive tasks (McCulloch & 
Marshall, 2004).  Subjects first performed single-task ambulation, in which they 
were asked to walk as quickly and safely as possible along a marked 6.1m long, 
19cm wide path.  An appropriate cognitive challenge (e.g. the longest random 
number sequence the individual could correctly recall) was then determined via 
administration of a seated forward digit span test.   
For the multi-task condition, subjects were read a random number 
sequence equivalent in length to their forward digit span performance.  
Immediately after the sequence was read, subjects performed the walking 
component of the test described previously.  Upon reaching the end of the path, 
they attempted to recall as many numbers as possible in the correct sequence.  
Subjects wore their normal footwear and were not allowed to utilize an assistive 
device while walking.  The number of correctly recalled digits, walking speed, and 
number of steps off of the path under both single- and multi-task conditions were 
averaged over 4 trials and recorded for analysis.          
2) The Pursuit Rotor Test (PRT, Figure 3.1B) is an internally developed version of a 
computerized measure of multi-tasking (Digital Electronics and Engineering 
Core, Biobehavioral Neursosciences and Communication Disorders Center, 
University of Kansas, Lawrence, KS) in which subjects used a trackball mouse 
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(Kensington Technology Group, Redwood Shores, CA) to pursue a target around 
an elliptical track while performing a verbal fluency task (Kemper, Schmalzried, 
Hoffman, & Herman, 2010).  The speed of the target was adjustable and could 
be varied from 0.2 to 2 rotations per minute.  The location of the mouse cursor 
was sampled every 100 ms, determining whether the cross-hairs were on- or off-
target and, if off-target, the distance off-target.  This data was averaged over 3 
successive 100 ms periods, generating a moving average of time on target and 
distance of error.   
Prior to testing, subjects practiced the computer task and target speed 
was adjusted until the average time on target plateaued and oscillated around 
80% accuracy.  A 1-minute tracking trial was then administered to determine 
single-task tracking performance.  Next, 2 trials of a single-task verbal fluency 
test were conducted, in which subjects were given a letter of the alphabet (F and 
M) and asked to say as many words as possible (excluding proper nouns) 
beginning with that letter in 1-minute.  The average number of words reported 
during these two trials reflected single-task verbal fluency.  Two trials of the multi-
tasking condition of the test followed, in which the participant tracked the target 
for 1-minute while simultaneously completing the verbal fluency task using 
different letters (B and L).  A final 1-minute single-task tracking trial completed 
the test, and the average time on target, error score, and number of words 
obtained under single- and dual-task conditions were recorded. 
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Gait and Functional Assessments 
1) Quantitative analysis of gait was performed using a GaitMat II gait analysis system 
(E.Q., Inc., Chalfont, PA). This system consists of a 4 meter long walkway housing 
38 rows of 256 pressure sensitive switches connected to a computer analysis 
system via a USB interface.  Subjects began walking approximately 2 meters prior to 
stepping onto the GaitMat, and were instructed to continue walking to a point 
approximately 2 meters beyond the GaitMat.  Three trials were conducted at each 
participant’s self-selected “normal” walking speed, followed by three trials in which 
they were instructed to walk “as quickly and safely as possible”.    Subjects wore 
their normal footwear, and were not allowed to utilize an assistive device during gait 
analysis. Gait velocity (in m/s) and stride length variability (expressed as the 
coefficient of variation: [SD/mean]*100) for both normal and fast walking conditions 
were collected and averaged across the 3 trials.   
2) The Late Life Function and Disability Instrument (LLFDI) is a comprehensive 
measure of physical function and disability specifically designed for older adult 
populations (Dubuc, Haley, Ni, Kooyoomjian, & Jette, 2004) The physical function 
component of the measure consists of 32 items evaluating self-reported difficulty in 
physical activities involving upper extremity function, lower extremity function, and 
advanced lower extremity function (e.g. running, etc.).  Subjects were asked “How 
much difficulty do you have doing [a particular activity] without the help of someone 
else and without the use of an assistive device?” and responded “none”, “a little”, 
“some”, “quite a lot”, or “cannot do.”  Overall physical functioning was scored on a 
scale of 0-100, with higher scores reflecting higher levels of function.   
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A further 16 items assessed the frequency of participation in and ability to 
perform major life tasks.  Subjects were asked how often they performed a particular 
task, and rated the extent to which they felt limited in that task with responses of “not 
at all,” “a little,” “somewhat,” “a lot,” and “completely”.  Frequency and disability 
indices were also scored on scales of 0-100, with higher scores reflecting a higher 
frequency of participation and a lower degree of disability.        
 
General Assessments 
1) The Mini-Mental Status Examination (MMSE) was used to assess global 
cognitive function.  This 30-point instrument broadly reflects orientation, memory, 
concentration, and praxis, and is sensitive to moderate to severe cognitive 
impairment (Folstein, Folstein, & McHugh, 1975).  As it seemed unlikely that 
severe cognitive deficits would be due exclusively to diabetes, any individual 
scoring < 26 on this measure was excluded from study participation. 
2) Beck’s Depression Inventory-II (BDI) was used to assess self-reported symptoms 
of depression.  This measure is scored on a 21-item, 63-point scale, with scores 
of 19 or less indicating minimal symptoms of depression, 20-28 moderate 
symptoms, and ≥ 29 severe symptoms (Beck, Steer, & Brown, 1996)  
3) The Rapid Assessment of Physical Activity (RAPA) was used to assess physical 
activity level (Topolski et al., 2006).  Subjects responded “yes or no” to 7 
questions describing their participation in physical activity.  Scores categorized 
subjects into one of 5 levels of activity: 1=sedentary, 2=underactive, 3=regular 
underactive (light activity), 4-5=regular underactive, and 6-7=regular active.   
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4) The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality and  
disturbance (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989)  This 
questionnaire consists of 19 self-rated questions comprising 7 component 
scores, each rated on a Likert scale of 0 (no difficulty) to 3 (severe difficulty).  
Addition of the 7 component scores generated a global score of 0-21.  A global 
score of 5 or greater indicated poor sleep quality. 
 
3.3.4 Statistical Analysis   
Data analysis was conducted using SPSS 16.0 for Windows (Chicago, IL). 
Normally distributed data are presented as mean ± standard deviation, and non-normal 
data as median (range).  Sample size was determined via an analysis of cognitive-
motor multi-tasking data from our pilot sample of individuals with diabetic peripheral 
neuropathy (Rucker et al., in press) and studies of cognitive-motor multi-tasking in 
healthy older adults (Shumway-Cook, Brauer, & Woollacott, 2000).  Based on an 
estimated effect size of 0.44, this analysis indicated that a sample of 40 subjects would 
yield a power of between 74 and 86%, depending upon the balance of discrete and 
overlapping information provided by the two measures of multi-tasking.   
Multi-tasking test components were analyzed, in part, as the percent change in 
performance, or dual-task cost, from single- to dual-task conditions.  This was 
calculated via the following formula:     
|Dual-task Cost| = (Dual-task performance – Single-task performance)      x 100 
                                                      Single-task performance 
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By convention, a positive dual-task cost reflected a decline in task performance from 
single- to dual-task conditions (e.g. a 5% decline in walking speed), whereas a negative 
dual-task cost represented an improvement in performance under dual-task conditions.   
In addition to the individual dual-task costs for each component of the two multi-taking 
measures, a total dual-task cost for each measure was calculated by averaging 
component costs.  For example, the total dual-task cost for the WART reflected the 
average of the dual-task costs elicited for digit span recall, walking speed, and steps off 
of the path.    
Data distribution and variance was examined via scatter and Q-Q plots, 
assessed with Kolmogorov-Smirnov and Shapiro-Wilk tests, and descriptive statistics 
were calculated for all variables.  One outlying data point was identified in steps off path 
on the WART; however analyses conducted with and without the data point were not 
statistically different and it was not removed from the final analysis. As subjects in the 
diabetes and comparison groups were paired, mean between- and within-group 
differences and 95% confidence intervals were examined via 2-tailed, 1 sample paired t-
tests.  The Wilcoxon signed rank test assessed differences in non-normally distributed 
data.  Pearson product moment and Spearman’s rank sum correlations explored the 
relationships between variables for normal and non-normally distributed data, 
respectively.  Type I error rate was set at 0.05. 
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 3.4 Results  
3.4.1 Sample Characteristics 
 Table 3.1 provides the general characteristics of the groups.  Forty individuals 
with type 2 diabetes (65% female) and 40 paired individuals without diabetes (65% 
female) consented and participated in this study.  Seventy-eight percent of the 
individuals in both groups were college educated, with the same percentage reporting a 
diagnosis of hypertension.   
Those with diabetes exhibited higher fasting blood glucose (p<0.001), were more 
obese (p<0.001), and had more symptoms of depression (p=0.04) than comparison 
subjects.  Longer term glycemic control in the diabetes group was also impaired (mean 
HbA1c 7.0±1.3%, range 5.4 – 11.2).  Eight subjects (20%) in this group reported a 
diagnosis of peripheral neuropathy, 2 (5%) mild retinopathy, and 1 (2.5%) nephropathy.  
A total of 6 subjects (15%) in the diabetes group and 2 in the comparison group (5%) 
reported having 2 or more falls in the preceding six months.  No significant between-
group differences were observed in age, global cognitive function, and self-reported 
physical activity level or sleep quality. 
           
3.4.2 Multi-tasking Performance 
 Results of the Walking and Remembering Test are provided in Table 3.1 and 
illustrated in Figures 3.2 and 3.3.  Pursuit Rotor Test results are reported in Table 3.1 
and illustrated in Figure 3.4.  Consistent with our primary hypothesis, the diabetes group 
demonstrated poorer overall performance on the WART (p=0.005); however we did not 
observe significant between-group differences in overall PRT performance (p=0.14). 
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Table 3.1:  Sample Characteristics and Testing Results 
 Diabetes  
(n=40) 
Comparison 
(n=40) 
P-value 95% CI 
Age  
(years) 
 
72.9 ± 8.3 72.9 ± 7.7 0.90 -1.1 – 1.2 
BMI  
(kg/m2) 
 
31.1 ± 4.7 26.6 ± 4.4 < 0.001 2.6 – 6.4 
FBG  
(mg/dL) 
 
134.3 ± 45.9 92.3 ± 14.1 < 0.001 25.0 – 51.3 
MMSE  
(score out of 30) 
 
28.7 ± 1.2 29.2 ± 1.0 0.07 -1.0 – 0.04 
BDI   
(score out of 63)  
 
4.5  
(0 – 28) 
3.0  
(0 – 31) 
0.04a -0.4 – 5.2 
RAPA 
(score out of 10) 
 
4.9 ± 1.3 4.8 ± 1.5 0.63 -0.6 – 0.9 
PSQI 
(score out of 21) 
 
5.0  
(1 – 12) 
4.0  
(1 – 18) 
0.34a -1.2 – 2.0 
WART Total Cost 
(% Change) 
 
34.7  
(-29.7 – 186.3)  
12.3 
(-24.1 – 171.3) 
0.005a 0.01 – 0.40 
PRT Total Cost 
(% Change) 
1.1 ± 12.8  4.7 ± 10.1 0.14 -0.1 – 0.01 
LLFDI – Frequency 
(score out of 100) 
56.3 ± 6.5 58.6 ± 9.7 0.42 -4.5 – 1.9 
LLFDI – Disability 
(score out of 100) 
79.7 ± 14.2 85.3 ± 13.8 0.05 -11.3 – 0.1 
LLFDI – Physical Function 
(score out of 100) 
60.6 ± 9.6 67.5 ± 8.2 < 0.001 -10.1 –  -3.7  
Table 3.1:  Data are presented as mean ± SD or
 
median (range).  
a 
Wilcoxon signed rank test.  
Abbreviations:  CI, Confidence Interval; BMI, body mass index; FBG, fasting blood glucose; MMSE, Mini-
Mental Status Examination; BDI, Beck’s Depression Inventory-II; RAPA, Rapid Assessment of Physical 
Activity; PSQI, Pittsburgh Sleep Quality Index; WART, Walking and Remembering Test; PRT, Pursuit 
Rotor Test; LLFDI, Late Life Function and Disability Index. 
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Walking and Remembering Test 
Analysis of WART components (Fig. 2 and 3) revealed that both groups 
demonstrated similar cognitive performance under single-task conditions (p=0.54); 
however those with diabetes ambulated more slowly (p<0.001) and took more steps off 
path (p<0.001).    Multi-tasking resulted in within-group declines in cognitive task 
performance (DM: p<0.001, CN: p<0.001) and gait stability (DM: p<0.001, CN: p=0.004) 
in both groups.  No significant changes in gait speed were observed in either group 
while multi-tasking (DM: p=0.79, CN: p=0.06).  Although the percent changes, or dual-
task costs, for cognitive task performance and gait speed were not different between the 
two groups (p=0.47 and 0.11, respectively), those with diabetes exhibited a greater 
decline in gait stability from single- to dual-task conditions (p=0.008). 
 
Pursuit Rotor Test 
 Analysis of PRT components (Fig. 4) revealed that both groups exhibited 
a similar amount of time on target (p=0.21) and distance of error (p=0.11) under single-
task conditions; however those with diabetes performed worse on the verbal fluency 
task (p=0.03).  Multi-tasking resulted in a decline in the amount of time on target in both 
groups (DM: p=0.002, CN: p<0.001), but did not significantly alter either verbal fluency 
performance (DM: p=0.42, CN: p=0.29) or the distance of error (DM: p=0.39, CN: 
p=0.55).  No between-group differences were noted in the dual-task costs for verbal 
fluency performance (p=0.05), time on target during tracking (p=0.49), or the distance of 
tracking error (p=0.80) (Fig. 4).   
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3.4.3 Quantitative Gait Analysis 
  Due to equipment malfunction, quantitative gait data could not be obtained for 3 
individuals, and data for the corresponding pair-matched subjects were also removed 
from the analysis.  Results from the 37 remaining pairs are illustrated in Figure 3.5.  
Individuals with diabetes ambulated more slowly than comparison subjects at a self-
selected “normal” walking pace (p=0.03), but with a similar degree of stride length 
variability (p=0.77).  When instructed to walk “as quickly and safely as possible”, those 
with diabetes demonstrated both slower speeds (p=0.001) and greater stride variability 
than comparison subjects (p=0.02). 
 
3.4.4 Late Life Function and Disability Index 
 Results of the Late Life Function and Disability Index are reported in Table 3.1.  
The groups scored similarly on the frequency (p=0.42) and disability (p=0.06) scales of 
the LLFDI; however those with diabetes scored significantly lower on the physical 
function component (p<0.001).    
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Figure 3.5:  Quantitative Gait Analysis During Normal and Fast Walking 
A) Gait Speed               
 
 
 
 
 
 
 
 
B) Gait Variability 
 
Figure 3.5: Gait speed and variability assessed in 36 subject pairs while normal walking (white bars) and 
fast walking (black bars).  *Significant between group difference at p<0.05.  ǂSignificant within-group 
difference at p<0.05.   
ǂ 
* 
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3.4.5 Relationships between Multi-tasking Performance and Gait and Functional Ability 
  Our secondary hypothesis was that multi-tasking performance would be 
significantly correlated with quantitative measures of gait and self-reported functional 
ability.  We used bivariate correlations to explore these relationships separately in the 
diabetes and comparison groups.  Table 3.2 provides the results of this analysis.  
Overall, the data did not support our hypothesis, revealing only small, non-significant 
relationships between total WART and PRT costs and gait speed, variability, and LLFDI 
scores in both groups. 
 
3.4.6 Other Relationships     
Post-hoc analysis revealed that self-reported symptoms of depression, physical 
activity level, and sleep quality were significantly related to gait and function in both 
groups.  Specifically, we observed that more symptoms of depression were associated 
with a slower normal walking gait speed (rs=-0.32, p=0.04) and poorer scores on all 
aspects of the LLFDI (frequency: r=physical function: rs=-0.56, p<0.001; disability: rs=-
0.44, p=0.005; physical function: rs=-0.35, p=0.03) in the diabetes group, and with a 
poorer LLFDI disability score in the comparison group (rs=-0.40, p=0.01).  Likewise, a 
higher physical activity level was correlated with less normal walking gait variability (rs=-
0.34, p=0.04), and higher scores on all LLFDI components (frequency: r=0.34, p=0.03; 
disability: r=0.35, p=0.03; physical function: r=0.39, p=0.01) in those with diabetes, and 
with an increased LLFDI frequency score (r=0.45, p=0.003) in comparison subjects.  
Poor sleep quality was related to poorer LLFDI disability (rs=-0.32, p=0.04) and physical 
function (rs=-0.37, p=0.02) scores in subjects with diabetes. 
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Table 3.2:  Multi-tasking and Other Correlates of Gait and Functional Ability 
A) Diabetes Group  
 Normal Gait Fast Gait Late Life Function and Disability 
Index 
Speed Variability Speed Variability Frequency Disability Function 
Age -0.31 0.20
a 
-0.38* 0.27 -0.25 -0.25 -0.35* 
BMI -0.05 -0.15
a 
0.07 -0.26 -0.19 -0.16 -0.27 
FBG -0.20 0.28
a 
-0.14 0.06 -0.29 -0.46** -0.22 
BDI -0.32
a* 0.19a -0.06a 0.16
a -0.56a** -0.44a* -0.35a* 
RAPA 0.31 -0.34
a* 0.32* -0.32 0.34* 0.35* 0.39* 
PSQI -0.10
a 0.08a 0.31a -0.12a -0.25a -0.32a* -0.37a* 
WART -0.07
a 0.22a -0.14a 0.29a -0.03a -0.03a 0.05a 
PRT 0.09
a -0.07a 0.11 -0.15
a 0.33a -0.03a -0.01a 
 
B) Comparison Group 
 Normal Gait Fast Gait Late Life Function and Disability 
Index 
Speed Variability Speed Variability Frequency Disability Function 
Age -0.35* 0.29
a 
-0.49** -0.01 -0.08 -0.08 -0.29 
BMI -0.45* 0.17
a 
-0.14 0.44** -0.02 -0.14 -0.27 
FBG -0.25 0.16
a 
-0.12 0.13 0.10 -0.15 -0.27 
BDI 0.02
a -0.19a 0.25a -0.24a -0.23a -0.40a** -0.07a 
RAPA -0.12 -0.14
a 
-0.11 -0.19 0.46** 0.17 0.05 
PSQI -0.04
a -0.01a 0.18a -0.02a -0.18a -0.22a 0.07a 
WART -0.06
a 0.09a 0.12a -0.14a 0.11a -0.06a 0.22a 
PRT -0.17
a 0.19a -0.15a -0.06a 0.24a 0.08a -0.05a 
Table 3.2: Abbreviations:  BMI, body mass index; FBG, fasting blood glucose; BDI, Beck’s Depression 
Inventory-II; RAPA, Rapid Assessment of Physical Activity Questionnaire; PSQI, Pittsburgh Sleep Quality 
Instrument; WART, Walking and Remembering Test; PRT, Pursuit Rotor Test. 
a
Spearman rank sum 
correlation coefficient. *Significant at p<0.05. **Significant at p≤0.01. 
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3.5 Discussion 
 This study is among the most detailed examinations of multi-tasking yet 
conducted in older adults with type 2 diabetes and, to our knowledge, is the first to 
explicitly characterize multi-tasking abilities in this population.  Specifically, we observed 
that older adults with diabetes performed worse than their non-diabetic counterparts on 
an ambulatory measure of multi-tasking.  Of even greater concern, however, was the 
fact that they appeared to self-prioritize competing task demands such that gait stability 
was sacrificed in order to preserve cognitive performance and walking speed. 
 To date we are aware of only one other investigation comparing multi-tasking 
abilities in older adults with and without diabetes.  Roman de Mettelinge et al. (2013) 
administered dual-task measures of walking while performing serial subtraction by 3 
and walking while reciting animal names to 28 older individuals with diabetes and 
peripheral neuropathy, 28 individuals with diabetes but no neuropathy, and 45 age- and 
sex-matched comparison subjects.  They found that both tasks negatively influenced 
gait speed, stride length, and stride time variability in both groups with diabetes.  These 
changes were not different between individuals with and without neuropathy; however 
they did appear to be magnified in those exhibiting poorer cognitive and executive 
function.      
 Although we did not examine differences in multi-tasking between individuals 
with and without neuropathy, our results expand upon this study in a number of 
important ways.  Like this group, we found that subjects with diabetes walked slower 
and with less stability than comparison subjects under both single- and dual-task 
conditions.  However, we did not observe a change in walking speed while multi-
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tasking.  Rather, our subjects maintained their speed, but at a substantial cost to gait 
stability.  While a corresponding decline in gait stability also occurred in the comparison 
group, the magnitude of this change (e.g. the dual-task cost) was significantly greater in 
those with diabetes.   
 One possible explanation for this difference is that the cognitive tasks employed 
in the previous study were more difficult for those with diabetes; possibly due to 
differences in educational level.  Consequently, these subjects may have been required 
to allocate resources to the cognitive task that comparison subjects were instead able to 
delegate to maintaining gait.  These tasks may have also been more difficult than our 
memory task, thereby explaining why we observed a decrease in stability but not in 
speed.  Such task difficulty problems are a common limitation of research employing 
dual-task methodology, particularly when data regarding educational level and cognitive 
task performance are not reported.  Our study addresses this limitation through the use 
of an individually prescribed cognitive task in subjects pair-matched for educational 
level.  Furthermore, our analysis of digit span performance revealed no significant 
between-group differences under either single- or dual-task conditions, indicating that 
our cognitive task was similarly challenging for both groups. 
 Another possible source of difference lays in the fact that these authors 
instructed their subjects to “concentrate equally on walking and the cognitive task”.  We 
did not provide subjects with explicit instructions for task prioritization.  Rather, we 
provided only implicit instruction to perform the WART “as quickly and safely as 
possible”, as this seemed more reflective of a real-world environment in which task 
priorities are rarely explicit or pre-established.  
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 Regardless, our WART results demonstrate that, in addition to being slower and 
more unstable both at baseline and while multi-tasking, this sample of older adults with 
diabetes performed worse on the WART as a whole, and largely failed to self-prioritize 
stability while walking in order to preserve other task demands.  All the more alarming, 
we observed this phenomenon in subjects both with and without peripheral neuropathy, 
and note that it appears to be more prominent in those who demonstrated the greatest 
degree of instability at baseline.  
 In an interesting counterpoint to our WART findings, however, we observed few 
differences between diabetes and comparison subjects in our non-ambulatory measure 
of multi-tasking, the PRT.  In this case, both groups appeared to minimize losses in 
verbal fluency and tracking error at the expense of target accuracy (e.g. time on target), 
and no between-group dual-task cost differences were elicited for any of the task 
components.  Taken together, our WART and PRT results seem to suggest that older 
adults with diabetes do not necessarily demonstrate global, gross impairments in multi-
tasking.  Rather more insidiously, these individuals may fail to adopt compensatory 
strategies that maximize safety during “high risk” situations in which simultaneous task 
demands outstrip attentional and/or functional resources. 
Given these implications, we were somewhat surprised to find little correlation 
between our multi-tasking assessments and measures of gait and functional ability.  
This may reflect the fact that our sample consisted of relatively high-functioning older 
adults, and the multi-tasking disturbances we observed were subtle.  As such changes 
may be largely sub-clinical, they may not strongly influence gait under normal conditions 
or self-reported measures of function and disability such as the LLFDI.  It is possible 
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that more pervasive deficits in multi-tasking would demonstrate more substantial 
relationships with these variables or, likewise, that more complex, challenging gait or 
functional scenarios would be more strongly associated with multi-tasking abilities.          
Our analyses did, however, reveal a number of striking relationships between 
symptoms of depression, physical activity level, and sleep quality and gait and physical 
function in both groups.  These findings contribute to an important but largely 
overlooked body of evidence linking such modifiable factors to gait (Brach et al., 2008; 
Rucker et al., in press) and functional deficits (Huang et al., 2012), and are especially 
critical for older adults with diabetes – a population known to exhibit a disproportionate 
prevalence of depression (Corriere, Rooparinesingh, & Kalyani, 2013), physical 
inactivity (Zhao, Ford, Li, & Balluz, 2011), and poor sleep quality (Resnick et al., 2003). 
 Certainly there are a number of factors that limit our interpretation of this data.  
First, our sample was of modest size and consisted primarily of Caucasian subjects of 
middle to upper socioeconomic status.  Although we accounted for the potentially 
confounding effect of educational level, future research will be necessary to determine 
whether our results can be generalized outside of this population.  In addition, it is 
important to note that we did not correct for the multiple correlations that explored the 
variables associated with gait and function in our study.  This limits the conclusions that 
can be drawn from this data; however our results clearly highlight interesting avenues 
for future research.        
 Another significant limitation is that we examined individuals both with and 
without diabetic peripheral neuropathy.  There is no question that somatosensory loss 
can significantly impact gait and function; however neuropathy is notoriously difficult to 
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diagnose and quantify.  In order to obtain an adequate sample of individuals with 
diabetes, as many as half of whom could potentially be expected to exhibit some 
symptoms of neuropathy (CDC, 2011), we opted to record whether individuals had been 
diagnosed with the condition but did not exclude them from the study. 
 Although the inclusion of these subjects undoubtedly complicates interpretation 
of the data, it also raises a very interesting question:  Why did these individuals, who 
would seem to have the highest fall risk and the smallest pool of functional resources 
from which to draw, fail to slow down in order to focus their attention on walking safely?  
In fact, the 8 subjects diagnosed with neuropathy actually increased their walking speed 
an average of 1% when required to multi-task, but at a cost of more than double the 
number of steps off path.  Further research will clearly be needed to explore how 
somatosensation and task demands interact to influence task prioritization and multi-
tasking during ambulation in this sub-population.     
 Certainly, it does not seem unreasonable to suspect that the multi-tasking 
phenomena observed in this study could contribute to falls in a population already at 
relatively high risk.  As yet, however, there are no established links between the 
changes we observed on the WART and falls or functional deficits, nor have fall risk cut-
offs been established for this instrument.  Future research should address these issues, 
and specifically explore the effect of manipulating and/or influencing task priorities and 
task demands, in order to more clearly examine whether function and safety can be 
better balanced during ambulatory multi-tasking activities. 
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3.6 Conclusions 
 This investigation provides evidence that older adults with type 2 diabetes exhibit 
deficits in the ability to multi-task while walking.  Although these changes do not appear 
to exert an undue influence on gait mechanics or function under normal circumstances, 
they may impair safety in more challenging situations.  Our data also suggest that 
modifiable but commonly overlooked factors, such as symptoms of depression, physical 
activity level, and sleep quality, may play an important role everyday gait and function.  
As such, clinicians should recognize that widely varying factors contribute to gait and 
physical dysfunction in older adults with type 2 diabetes, and be prepared to assess and 
intervene appropriately. 
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Chapter 4 Preface 
In Chapter 3 we demonstrated significant changes in gait stability when our 
sample of older adults with type 2 diabetes was asked to multi-task while walking.  The 
next step in our planned analysis involved a more detailed exploration of the influence 
of multi-tasking ability on spatiotemporal parameters of single-task gait and self-
reported levels of physical function and limitation in everyday activities in this 
population.  Somewhat to our surprise, the preliminary analysis of these relationships 
revealed very little correlation between multi-tasking and either gait or functional ability.  
However, we did observe rather striking associations between these variables and 
symptoms of depression, physical activity level, and sleep quality – all factors known to 
disproportionately affect those with diabetes.   
In the context of these findings, we first completed our planned series of 
regression models, in which Walking and Remembering and Pursuit Rotor Test 
outcomes were used to predict criterion measures of gait velocity, stride length 
variability, physical function, and disability in subjects with diabetes.  We then 
constructed an additional series of models exploring the effects of depression, physical 
activity level, and sleep quality on the same set of criterion variables.  Together, these 
analyses comprise Chapter 4.      
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Chapter 4 
 
 
 
 
 
 
 
 
 
The Contribution of Multi-tasking to Gait and Functional Ability in Older Adults with Type 
2 Diabetes 
 
 
 
 
 
 
 
 
 
A version of this chapter is in preparation for submission to The Journal of Geriatric 
Physical Therapy (2014) 
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4.1 Abstract  
BACKGROUND AND PURPOSE: It is unclear whether the ability to multi-task 
contributes to the disproportionate risk of functional impairment and disability in older 
adults with type 2 diabetes.  We examined the relationships between multi-tasking 
ability and spatiotemporal gait parameters and self-reported physical function and 
disability in this population.  METHODS: Forty individuals with type 2 DM were 
examined.  Multi-tasking was assessed during ambulation via the Walking and 
Remembering Test (WART), and while seated via the Pursuit Rotor Test (PRT).  Self-
selected normal and fast walking speed and stride length variability were measured 
using a GaitMat II System, and self-reported functional ability assessed via the Late Life 
Function and Disability Index (LLFDI).  Symptoms of depression, physical activity level, 
and sleep quality were also assessed.  RESULTS:  Multi-tasking ability was not 
significantly associated with gait speed or variability under either normal or fast walking 
conditions, or with self-reported physical function or disability.  Secondary analyses 
revealed significant adverse relationships between higher depression levels and fast 
walking variability and disability, lower physical activity levels and both normal and fast 
walking speed and physical function, and poorer sleep quality and normal walking 
variability.  CONCLUSIONS:  Multi-tasking ability has relatively little influence on single-
task gait parameters or self-reported levels physical function and disability in older 
adults with type 2 diabetes.  However, potentially modifiable factors such as depression, 
physical activity level, and sleep quality may significantly affect these variables.  Future 
research should explore how neuropsychological function, physical activity, and sleep 
interact with different aspects of physical function in older adults with diabetes.   
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4.2 Introduction 
Diabetes can profoundly interfere with everyday function, and current estimates 
suggest that as many as half of all individuals with diabetes suffer from some form of 
disability – a rate 2-3 times greater than that observed in the non-diabetic population 
(Gregg et al., 2000).  These disabilities often arise from impairments in physical 
function, mobility, and the ability to perform routine functional activities, and have a 
direct impact on employability, socio-economic status, and health care access.  This, in 
turn, has far-reaching social, economic, political, and public health implications (Centers 
for Disease Control and Prevention [CDC], 2011).               
 Commonly, this increased risk for functional impairment and disability is 
attributed to the major vascular and neuropathic sequelae of diabetes.  While these 
factors undoubtedly contribute to functional loss, it is increasingly acknowledged that 
less commonly recognized comorbidities, such as cognitive and neuropsychiatric 
dysfunction, may also be of substantial importance (Volpato, Maraldi, & Fellin, 2009).  In 
particular, deficits in executive function – the ability to plan, organize, sequence, and 
monitor the processes underlying goal-oriented behavior – appear to be strong 
predictors of functional deterioration (Cahn-Weiner, Malloy, Boyle, Marran, & Salloway, 
2000). 
 Executive dysfunction has been observed in older individuals with diabetes (Kodl 
& Seaquist, 2008), and several studies have indicated that even relatively insidious 
executive deficits can produce impairments in gait (Brach, Talkowski, Strotmeyer, & 
Newman, 2008; Kuo, Leveille, Yu, & Milberg, 2007) and activities of daily living in this 
population (Kuo et al., 2007; McGuire, Ford, & Ajani, 2006).  Of specific interest in 
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relation to these findings is the executive ability responsible for dividing attention 
between simultaneous activities, or multi-tasking.  Deficits in multi-tasking have been 
linked to both gait and functional impairments in many high risk populations (Dubost et 
al., 2006; Hausdorff, Balash, & Giladi, 2003; Hyndman & Ashburn, 2003; Sheridan, 
Solomont, Kowall, & Hausdorff, 2003), including those with diabetes (Paul, Ellis, Leese, 
McFadyen, & McMurray, 2009; Roman de Mettelinge et al., 2013), and may play a role 
in mediating the association between executive dysfunction and physical function and 
disability.   
This study is among the first to examine the specific contributions of multi-tasking 
to gait and every day physical function and disability in older adults with diabetes, and to 
explore how other under-recognized comorbidities may influence these variables.  Our 
primary hypothesis was that multi-tasking ability would significantly predict quantitative 
gait speed and variability during single-task walking, as well as self-reported levels of 
physical function and disability.  A secondary aim was to explore the influence of 
depression, physical activity level, and sleep quality on the same criterion variables of 
gait and function. 
 
4.3 Methods 
4.3.1 Study Design and Sample 
Institutional approval for this cross-sectional study was granted by the Human 
Subjects Committee of the University of Kansas Medical Center.  Data was gathered 
from a total of 40 individuals aged 60 years and older with a medical diagnosis of type 2 
diabetes.  Each subject received a $50 stipend upon completing the study.  Exclusion 
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criteria included the following:  1) known history of central nervous system pathology, 2) 
musculoskeletal or orthopedic conditions significantly affecting gait and/or balance, 3) 
inability to ambulate without an assistive device, 4) self-reported body mass index of > 
45 kg/m2, 5) uncorrectable visual/auditory deficits or color blindness, 6) wounds on the 
weight bearing surfaces of the feet, 7) less than a high school level of education, and/or 
8) cognitive impairment as evidenced by a score of ≥ 2 on the AD8 Dementia Screening 
Interview or a score of < 26 on the Mini-Mental Status Examination.        
 
4.3.2 Procedures   
 Following telephone screening and the signature of an institutionally-approved 
informed consent form, data regarding age, height, weight, medical and diabetic 
comorbidities, and current medications were gathered.  Fasting blood glucose 
measurements (Contour Blood Glucose Monitoring System, Bayer, Tarrytown, NY) and 
glycosylated hemoglobin levels (HbA1c; Metrika A1CNow+, Bayer, Tarrytown, NY) were 
then obtained from each subject.  A small snack was made available once fasting blood 
glucose level was established.  All subjects were tested in a normoglycemic state, 
defined as a blood glucose level of between 80 and 250 mg/dL. 
 After glycemic testing, each subject was administered a series of questionnaires 
assessing symptoms of depression, physical activity level, sleep quality, and functional 
ability.  This was followed by two randomly ordered measures of multi-tasking, the 
Walking and Remembering and Pursuit Rotor Tests, and quantitative analysis of gait 
speed and variability.  All testing was conducted by the same research personnel in a 
quiet laboratory setting to minimize distraction. 
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4.3.3 Measures 
Multi-tasking Assessments 
1)  The Walking and Remembering Test (WART; Chapter 3, Figure 3.1A) was used to     
assess multi-tasking ability during gait (McCulloch & Marshall, 2004). As described 
in Chapter 3, subjects first performed single-task ambulation, in which they were 
asked to walk as quickly and safely as possible along a marked 6.1m long, 19cm 
wide path.  An appropriate cognitive challenge (e.g. the longest random number 
sequence the individual could correctly recall) was then determined via 
administration of a seated forward digit span test. 
 For the multi-task condition, subjects were read a random number sequence 
equivalent in length to their forward digit span performance.  Immediately after the 
sequence was read, subjects performed the walking component of the test 
described previously.  Upon reaching the end of the path, they attempted to recall as 
many numbers as possible in the correct sequence.  Subjects wore their normal 
footwear and were not allowed to utilize an assistive device while walking.  The 
number of correctly recalled digits, walking speed, and number of steps off of the 
path under both single- and multi-task conditions were averaged over 4 trials and 
recorded for analysis. 
2) The Pursuit Rotor Test (PRT; Chapter 3, Figure 3.1B) was used to assess multi- 
tasking in a non-gait situation (Kemper, Schmalzried, Herman, Leedahl, & 
Mohankumar, 2009). As described in Chapter 3, subjects used a trackball mouse 
(Kensington Technology Group, Redwood Shores, CA) to pursue a target around an 
elliptical track while performing a verbal task.  The speed of the target was 
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adjustable and could be varied from 0.2 to 2 rotations per minute.  The location of 
the mouse cursor was sampled every 100 ms, determining whether the cross-hairs 
were on- or off-target and, if off-target, the distance off-target.  This data was 
averaged over 3 successive 100 ms periods, generating a moving average of time 
on target and distance of error. 
 Prior to testing, subjects practiced the computer task and target speed was 
adjusted until the average time on target plateaued and oscillated around 80% 
accuracy.  A 1-minute tracking trial was then administered to determine single-task 
tracking performance.  Next, two trials of a single-task verbal fluency test were 
conducted, in which subjects were given a letter of the alphabet (F and M) and 
asked to say as many words as possible (excluding proper nouns) beginning with 
that letter in 1-minute.  The average number of words reported during these two 
trials reflected single-task verbal fluency.  Two trials of the multi-tasking condition of 
the test followed, in which the participant tracked the target for 1-minute while 
simultaneously completing the verbal fluency task using different letters (B and L).  A 
final 1-minute single-task tracking trial completed the test, and the average time on 
target, error score, and number of words obtained under single- and dual-task 
conditions were recorded. 
 
Gait and Functional Assessments 
1) Quantitative analysis of gait was performed using a GaitMat II gait analysis system 
(E.Q., Inc., Chalfont, PA). This system consists of a 4 meter long walkway housing 
38 rows of 256 pressure sensitive switches connected to a computer analysis 
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system via a USB interface.  Subjects began walking approximately 2 meters prior to 
stepping onto the GaitMat, and were instructed to walk to a point approximately 2 
meters beyond the GaitMat.  Three trials were conducted at each participant’s self-
selected usual walking speed (e.g. normal walking), followed by three trials in which 
they were instructed to walk “as quickly and safely as possible” (e.g. fast walking).    
Subjects wore their normal footwear, and were not allowed to utilize an assistive 
device during gait analysis. Gait velocity (in m/s) and stride length variability 
(expressed as the coefficient of variation: [standard devidation/mean]*100) for both 
normal and fast walking conditions were collected and averaged across the 3 trials.   
2) The Late Life Function and Disability Instrument (LLFDI) is a comprehensive 
measure of physical function and disability specifically designed for older adult 
populations (Dubuc, Haley, Ni, Kooyoomjian, & Jette, 2004).  The physical function 
component of the measure consists of 32 items evaluating self-reported difficulty in 
physical activities involving upper extremity function, lower extremity function, and 
advanced lower extremity function (e.g. running, etc.).  Subjects were asked “How 
much difficulty do you have doing [a particular activity] without the help of someone 
else and without the use of an assistive device?” and responded “none”, “a little”,  
“some”, “quite a lot”, or “cannot do.”  Overall physical functioning was scored on a 
scale of 0-100, with higher scores reflecting higher levels of function.   
A further 16 items assessed the ability to perform major life tasks.  Subjects rated 
the extent to which they felt limited in various tasks with responses of “not at all,” “a 
little,” “somewhat,” “a lot,” and “completely”.  The disability index was also scored on 
scales of 0-100, with higher scores reflecting a lower degree of disability.        
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Other Assessments 
1) Beck’s Depression Inventory-II (BDI) was used to assess self-reported symptoms of 
depression.  This measure is scored on a 21-item, 63-point scale, with scores of 19 
or less indicating minimal symptoms of depression, 20-28 moderate symptoms, and 
≥ 29 severe symptoms (Beck, Steer, & Brown, 1996). 
2)  The Rapid Assessment of Physical Activity (RAPA) was used to assess physical  
activity level (Topolski et al., 2006).  Subjects responded “yes or no” to 7 questions 
describing their usual level of participation in physical activity.  Scores categorized 
subjects into one of 5 levels of activity: 1=sedentary, 2=under-active, 3=regular 
under-active (light activity), 4-5=regular under-active, and 6-7=regular active.   
1) The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality 
(Buysse, Reynolds, Monk, Berman, & Kupfer, 1989).  This questionnaire consists of 
19 self-rated questions comprising 7 component scores, each rated on a Likert scale 
of 0 (no difficulty) to 3 (severe difficulty).  Addition of the 7 component scores 
generated a global score of 0-21, with a score of 5 or indicating poor sleep quality. 
 
4.3.4 Statistical Analysis   
Data analysis was conducted using SPSS 16.0 for Windows (Chicago, IL). 
Normally distributed data are described as mean ± standard deviation, and non-normal 
data as median (range).   
Multi-tasking abilities were described as the percent change in performance, or 
dual-task cost, from single- to dual-task conditions.  This was calculated via the 
following formula:     
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|Dual-task Cost| = (Dual-task performance – Single-task performance)      x 100 
                                                      Single-task performance 
By convention, positive dual-task costs reflect a decline in performance from single- to 
dual-task conditions (e.g. a 5% decline in walking speed), whereas negative dual-task 
costs represent an improvement in performance under dual-task conditions.  Dual-task 
costs were calculated for each component of the two multi-tasking measures, and a 
total dual-task cost for each measure was calculated by averaging the component 
costs.  For example, the total dual-task cost for the WART reflected the average of the 
dual-task costs elicited for digit span recall, walking speed, and steps off of the path.  
Total dual-task costs for the WART and PRT were then averaged to generate a single 
predictor variable of multi-tasking ability:  overall dual-task cost. 
 Next, a backward model building procedure was used to construct a series of 
multiple linear regression models, and the squared multiple correlation (R2), 
unstandardized (B), and standardized (β) regression coefficients utilized to examine the 
collective and individual effects of overall multi-tasking cost, along with covariates of 
age and glycemic control (HbA1c), on quantitative measures of gait velocity and stride 
length variability.  This procedure, with an additional covariate of BDI score of 
depression symptoms, also examined the effect of overall multi-tasking ability and self-
reported physical function and disability (Table 4.1A).  Finally, the backwards model 
building procedure was repeated in a post-hoc secondary analysis exploring the effects 
of symptoms of depression, physical activity level, and sleep quality on the same 
criterion measures (Table 4.1B).  An alpha level of 0.05 assessed the significance of all 
relationships.   
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Table 4.1A: Primary Regression Models 
     
Model 1a:  
Normal Gait Velocity 
 
 
 
 
 
a + b1 (age) + b2 (glycemic control) + b3 (overall dual-task 
cost) + e 
 
 
Model 1b: 
Fast Gait Velocity 
 
Model 2a: 
Normal Stride 
Variability 
 
Model 2b: 
Fast Stride Variability 
Model 3: 
Physical Function 
 
 
a + b1 (age) + b2 (glycemic control) + b3 (depression) + b4 
(overall dual-task cost) + e 
 
 
Model 4: 
Disability  
 
Table 4.1B:  Secondary Regression Models 
     
Model 5a:  
Normal Gait Velocity 
 
 
 
 
 
 
 
 
a + b1 (depression) + b2 (physical activity level) + b3 (sleep 
quality) + e 
 
 
Model 5b: 
Fast Gait Velocity 
 
Model 6a: 
Normal Stride 
Variability 
 
Model 6b: 
Fast Stride Variability 
 
Model 7: 
Physical Function 
 
Model 8: 
Disability  
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4.4 RESULTS 
4.4.1 Sample Characteristics 
The general characteristics of this group of 40 community dwelling individuals 
aged 60 and older with type 2 diabetes are provided in Table 4.2.  Briefly, the group 
consisted of 26 females (65%) and 14 males (35%), with an overall group mean age of 
72.9 ± 8.3 years.  Thirty-one (78%) were college educated.  As expected, glycemic 
control was impaired to both short-term (mean fasting blood glucose 134.3 ± 45.9 
mg/dL) and long-term (median HbA1c 6.8%, range 5.4 – 11.2) measures.  The median 
time since diagnosis with diabetes was 10 years (range 1- 40), with 8 subjects (20%) 
reporting disease-related complications of peripheral neuropathy, 2 (5%) mild 
retinopathy, and 1 (2.5%) nephropathy.   
 
4.4.2 Multi-tasking Performance 
As described and illustrated in Chapter 3, multi-tasking demands during the 
WART resulted in significant within-group declines in both cognitive task performance 
(p<0.001) and gait stability (p<0.001).  No significant dual-task changes were observed 
in gait speed (p=0.79).  Multi-tasking during the PRT resulted in a decline in the amount 
of time on target while tracking (p=0.002), but did not significantly alter either verbal 
fluency (p=0.42) or distance of tracking error (p=0.39).  Total dual-task costs for the 
WART and PRT were 44.4% and 1.1%, respectively, yielding an overall dual-task cost 
of 22.6%.1 
                                                          
1
 Due to the large difference in the dual-task costs elicited on the WART and PRT, a parallel regression analysis was 
conducted using total WART task cost in lieu of the overall task cost.  These results did not differ substantially from 
the planned analysis reported here. 
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Table 4.2:  Sample Characteristics 
   
Age  
(years) 
 
72.9 ± 8.3 
Body Mass Index  
(kg/m2) 
 
31.1 ± 4.7 
Time Since Diagnosis 
(years) 
 
10 (1-40) 
Fasting Blood Glucose 
(mg/dL) 
 
134.3 ± 45.9 
Glycosylated Hemoglobin 
(%) 
 
6.8 (5.4-11.2) 
Mini-Mental Status Examination 
(score out of 30) 
 
28.7 ± 1.2 
Beck’s Depression Inventory-II 
(score out of 63)  
 
4.5 (0 – 28) 
Rapid Assessment of Physical Activity 
(score out of 10) 
 
4.9 ± 1.3 
Pittsburgh Sleep Quality Index 
(score out of 21) 
 
5.0 (1 – 12) 
Table 4.2:  Data are mean ± SD or median (range). Abbreviations: BMI, body mass index; FBG, fasting 
blood glucose; HbA1c, glycosylated hemoglobin; MMSE, Mini-Mental Status Examination; BDI, Beck’s 
Depression Inventory-II; RAPA, Rapid Assessment of Physical Activity; PSQI, Pittsburgh Sleep Quality 
Index. 
 
4.4.3 Quantitative Gait Analysis 
Due to equipment malfunction, quantitative gait data could not be obtained for 3 
subjects.  At their self-selected “normal” walking speed the remaining 37 subjects 
ambulated at an average rate of 1.0 ± 0.2 m/s, with a stride length variability of 5.2 ± 
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2.9%.  When asked to ambulate “as quickly and safely as possible” for fast walking 
trials, subjects ambulated at an average rate of 1.4 ± 0.4 m/s, with a stride variability of 
5.2 ± 2.5%.    
 
4.4.4 Late Life Function and Disability Index 
 Physical function and disability scales of the LLFDI yielded mean scores of 60.6 
± 9.6 and 79.7 ± 14.2, respectively.  Both reflect “slight limitations” according to 
classifications described by Lapier and Mizner (2009). 
 
4.4.5 Additional Measures 
 On average, subjects reported minimal symptoms of depression (BDI score 6.6 ± 
6.1), a regular but under-active level of physical activity (RAPA score 4.9 ± 1.3), and 
poor sleep quality (PSQI score 5.7 ± 3.0). 
 
4.4.6 Effect of Multi-tasking on Spatiotemporal Measures of Gait 
 Results of regression models 1 and 2 are provided in Table 4.3.  Contrary to our 
primary hypotheses, the overall dual-task cost elicited by our multi-tasking measures 
was not associated with either gait velocity (beta=-0.05, p=0.76) or variability        
(beta=-0.12, p=0.50) at self-selected “normal” speed, when controlled for age and 
glycemic control.  Together, these 3 factors accounted for only a very small portions of 
the variation in gait speed (R2=0.017, p=0.89) during normal walking, with backwards 
elimination resulting in the respective removal of age (model R2=0.015, p=0.75), multi-
tasking cost (model R2=0.013, p=0.48), and HbA1c (all variables removed from model).  
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Similarly, these factors explained only a small portion of the variation in normal stride 
length variability during normal walking (R2=-0.035, p=0.75), with subsequent models 
removing HbA1c (model R2=0.033, p=0.57), multi-tasking cost (model R2=0.019, 
p=0.42), and age (all variables removed from model). 
There was also little relationship between overall multi-tasking cost and gait 
velocity (beta=0.004, p=0.98) or stride variability (beta=-0.18, p=0.29) under fast 
walking conditions, and multi-tasking cost, age, and HbA1c together predicted only 
small amounts of the variation in these variables (gait velocity: R2=0.033, p=0.75; stride 
length variability: R2=-0.064, p=0.53).  For fast walking speed, backwards elimination 
resulted in the respective removal of multi-tasking cost (model R2=0.032, p=0.54), age 
(model R2=0.030, p=0.29), and HbA1c (all variables removed from model).  For fast 
walking stride length variability, backwards elimination resulted in the respective 
removal of HbA1c (model R2=0.048, p=0.43), age (model R2=0.027, p=0.33), and multi-
tasking cost (all variables removed from model).  No significant interactions were 
observed in any of the models.   
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HbA1c (model R2=0.207, p=0.003).  Symptoms of depression remained significantly 
associated with physical function in the final model (beta=-0.455, p=0.003).   
 Although the combination of multi-tasking cost, age, glycemic control, and 
symptoms of depression also predicted significant portions of the variation in disability 
(R2=0.278, p=0.02), there was little association between multi-tasking cost and disability 
(beta=0.035, p=0.81).  Backward elimination resulted in the respective removal of 
HbA1c (model R2=0.277, p=0.008), multi-tasking cost (model R2=0.276, p=0.003), and 
age (model R2=0.255, p=0.001).  Symptoms of depression remained significantly 
associated with disability in the final model (beta=-0.505, p=0.001).  No significant 
interactions were observed in either model.    
 
Table 4.4:  Effect of Age, Glycemic Control, and Multi-tasking Ability on LLFDI 
Physical Function and Disability Scores 
 Model 3: 
Physical Function 
                 Model 4: 
                Disability 
Variable B SE B β B SE B β 
Age 0.130 0.194 0.100 -0.249 0.240 -0.151 
Glycosylated 
Hemoglobin 
-1.072 1.271 -0.127 -0.234 1.569 -0.022 
Depression -0.949 0.304 -0.472* -1.268 0.375 -0.497* 
Overall Multi-
tasking Cost 
2.546 6.756 0.057 2.000 8.342 0.035 
R2   0.236*    0.278*  
F Statistic  2.702   3.363  
Table 4.4:  Results from the full model (e.g. all variables included) are shown.  Abbreviations: B, 
Unstandardized coefficients; SE B, standard error of unstandardized coefficients; β, Standardized 
coefficients. *Significant at p<0.05.   
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4.4.8 Effects of Depression, Physical Activity Level, and Sleep Quality on Gait 
 Results of regression models 5 and 6 are provided in Table 4.5.  This exploratory 
analysis of the effects of depression symptoms, physical activity level, and sleep quality 
on gait velocity and variability revealed moderately strong and statistically significant 
relationships between physical activity level and normal walking gait speed (beta=0.357, 
p=0.03), with all 3 variables combined accounting for a statistically significant 21% of 
the variation in gait speed (R2=0.210, p=0.04).  Backwards elimination resulted in the 
respective removal of sleep quality (model R2=0.209, p=0.01) and symptoms of 
depression (model R2=0.163, p=0.01), while physical activity level remained significantly 
associated with gait speed in the final model (beta=0.403, p=0.01).  In contrast, sleep 
quality was significantly associated with stride length variability under normal walking 
conditions (beta=0.194, p=0.02), with the combination of all 3 factors predicting a non-
significant 18% of the variation in this criterion (R2=0.178, p=0.09).  Backwards 
elimination resulted in the respective removal of symptoms of depression (model 
R2=0.174, p=0.04) and physical activity level (model R2=0.166, p=0.01), while sleep 
quality remained significantly associated with stride length variability in the final model 
(beta=0.408, p=0.01). 
Physical activity level continued to demonstrate a moderate association with gait 
speed under fast walking conditions (beta=0.385, p=0.02), and the combination of all 3 
factors accounted for a significant proportion of the variation in fast walking gait speed 
(R2=0.209, p=0.04).  Backwards elimination resulted in the removal of symptoms of 
depression (model R2=0.204, p=0.02) and sleep quality (model R2=0.158, p=0.01) 
respectively, while physical activity level remained significantly associated with fast 
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4.4.9 Effects of Depression, Physical Activity Level, and Sleep Quality on Function    
Results of regression models 7 and 8 are provided in Table 4.6.  Physical activity 
level demonstrated a significant and moderately strong relationship to self-reported 
physical function on the LLFDI (beta=0.371, p=0.01), and this variable, together with 
depression and sleep quality, predicted a significant portion of the variation in this 
criterion variable (R2=0.378, p=0.001).  Backwards elimination removed symptoms of 
depression (model R2=0.331, p=0.001), leaving both physical activity level (beta=0.434, 
p=0.003) and sleep quality (beta=-0.394, p=0.006) in the final model.      
Similarly, depression symptoms demonstrated a moderately strong and 
statistically significant association with LLFDI disability score (beta=-0.409, p=0.01) and, 
together, the 3 variables explained a statistically significant 31% of the variation in 
disability scores (R2=0.311, p=0.004).  Backwards elimination removed sleep quality 
(model R2=0.304, p=0.001) and physical activity level (model R2=0.255, p=0.001), 
respectively, leaving only symptoms of depression (beta=-0.505, p=0.001) in the final 
model.  No significant interactions were observed in either model.  
 
4.5 DISCUSSION 
 This study is among the first to examine the specific contributions of multi-tasking 
to single-task gait and functional outcomes in older adults with type 2 diabetes.  Our 
findings suggest that multi-tasking disrupts gait stability when performed while walking.  
However, the ability to multi-task itself appears to play only a small role in ambulation 
under single-task conditions and, likewise, appears to exert little influence on self-
reported levels of physical function and disability in this population. 
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Table 4.6:  Effect of Depression, Physical Activity Level, and Sleep Quality on  
LLFDI Physical Function and Disability Scores 
              Model 7: 
      Physical Function 
  Model 8: 
 Disability 
Variable B SE B β B SE B β 
Depression -0.498 0.301 -0.248 -1.043 0.403 -0.409* 
Physical Activity 
Level 
1.680 0.621 0.371* 1.389 0.829 0.241 
Sleep Quality -1.030 0.517 -0.290 -0.424 0.691 -0.094 
R2                0.378**    0.311** 
F Statistic    7.290   5.412 
Table 4.6:  Results from the full model (e.g. all variables included) are shown.  Abbreviations: B, 
Unstandardized coefficients; SE B, standard error of unstandardized coefficients; β, Standardized 
coefficients. *Significant at p<0.05, **Significant at p<0.01.   
 
 As described in Chapter 3, the results of this investigation are consistent with 
others in demonstrating that multi-tasking while walking can impair spatiotemporal gait 
characteristics in older adults with diabetes (Paul et al., 2009; Roman de Mettelinge et 
al., 2013).  However, we are unaware of any previous attempts to examine whether 
multi-tasking abilities influence single-task gait in this population.  Our study found little 
association between these variables, supporting current neuropsychological models 
describing executive function as active “only when the novelty and/or complexity of a 
given situation precludes an automatic, routine response” (Suchy, 2009, p. 106).  That 
multi-tasking was not significantly associated with either normal or fast walking gait 
parameters in our sample of relatively high-functioning older adults with diabetes may 
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indicate that even fast walking remained a relatively automatic process in this group, 
requiring minimal attention and/or executive input.   
 In much the same way, we observed little association between overall multi-
tasking ability and physical function or disability.  This may also be partly attributable to 
the high-functioning nature of our sample, which generally reported only “slight” levels of 
physical impairment and disability.  As a result, the relatively subtle changes we 
observed in multi-tasking abilities may have exerted little influence on these variables.  
It would seem worthwhile for future research to examine whether multi-tasking exhibits 
a stronger association with gait under more complex conditions than those employed in 
our study or, conversely, whether multi-tasking deficits can eventually become 
pervasive enough to influence single-task gait parameters, physical function, and/or 
disability in this and other populations.  
 The results of our investigation may also provide some context for studies of 
dual-task training interventions, which have been shown to improve gait and balance 
under dual-task conditions in elderly adults (Silsupadol, Lugade, et al., 2009; Silsupadol, 
Shumway-Cook, et al., 2009; You et al., 2009) and those with dementia (Schwenk, 
Zieschang, Oster, & Hauer, 2010), but have little effect on single-task performance, and 
vice versa.  This training specificity may arise because the resources necessary to 
maintain gait and balance under single-task conditions are somewhat distinct from 
those required during multi-tasking, particularly in terms of the need for executive input.  
Our study did not address this issue directly; however the lack of association we 
observed between multi-tasking ability and single-task gait parameters is broadly 
consistent with such hypotheses.  
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 Also of considerable interest are our secondary findings that depression, physical 
activity level, and sleep quality each contributed significantly to at least one gait or 
functional measure.  In particular, the beneficial effect of physical activity on gait velocity 
and self-reported physical function further emphasizes the critical role of physical 
activity in the management of type 2 diabetes.  Likewise, the negative effects of 
depression and poor sleep quality on gait variability and disability suggest that the 
identification and treatment of these common comorbidities may have important 
functional implications for this population, and should not be trivialized.   
 Although these findings are very interesting, it is important to acknowledge that 
several factors limit interpretation of the data.  First among these is the relatively small 
size of our sample, which clearly limits the power of our regression analysis.  Further, 
this sample consisted largely of high functioning older individuals with impaired but 
generally well-maintained glycemic control.  It is currently unclear whether our findings 
can be extrapolated to other individuals with diabetes, and how variables such as multi-
tasking ability, depression, physical activity, and sleep quality might relate to gait and/or 
functional abilities in subjects with fewer cognitive or physical resources, or in those with 
more poorly controlled diabetes.   
It is also somewhat difficult to determine the clinical significance of our findings, 
particularly with regard to gait velocity and variability.  Previous research has indicated 
that an increase of as little as 3% in stride length variability may nearly double fall risk 
(Maki, 1997), while self-selected normal gait speeds below 1 m/s have been linked to an 
increased risk for hospitalization and death (Cesari et al., 2005).  We did not observe a 
substantial increase in stride length variability from normal to fast gait conditions in our 
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subjects; however their normal gait speed averaged only 1.0±0.3 m/s, with well over a 
third of the group (40.5%, n=15) ambulating below this cut-off rate.  Further research will 
be needed to determine the effects of depression, physical activity level, and sleep 
quality on gait and physical function in those with diabetes, and elucidate the 
mechanisms that may underlie these relationships in those with diabetes and other 
populations at high risk for functional impairments and disability.    
 
4.6 Conclusions 
Overall, the results of our investigation indicate that multi-tasking while walking 
negatively affects gait stability in community dwelling older adults with type 2 diabetes.  
However, multi-tasking ability itself has relatively little influence on gait velocity or 
variability under single-task conditions, or on self-reported levels of physical function or 
disability in these individuals.  Our data do suggest that potentially treatable and/or 
modifiable factors such as depression, physical activity level, and sleep quality may 
exert substantial influence on important aspects of both quantifiable and self-perceived 
physical function in this population.  This emphasizes the importance of appropriately 
identifying and treating such common comorbidities, and highlights the need for further 
research exploring how executive and neuropsychiatric function, physical activity, and 
sleep influence different aspects of physical function in those with diabetes. 
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Chapter 5 Preface 
Previous chapters have demonstrated that multi-tasking while walking can 
adversely affect gait stability in older adults with type 2 diabetes, although multi-tasking 
ability itself appears to have relatively little influence on single-task gait measures or 
self-reported levels of physical function and disability.  However, multi-tasking is 
generally considered to be only one of a variety of executive functions, and the integrity 
and functional contributions of other executive abilities remain largely unknown in this 
population.  
Therefore, alongside our multi-tasking tests, we also administered a battery of 10 
executive measures assessing attention shifting, information updating, response 
inhibition, visuospatial organization, and verbal logical memory to each subject in both 
the diabetes and comparison groups.  Our analyses of the results obtained from this 
executive testing battery, and our exploration of the relationships between these abilities 
and measures of gait and function, comprise Chapter 5.      
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Chapter 5 
 
 
 
 
 
 
 
 
 
The Integrity of Other Executive Functions in Older Adults with Type 2 Diabetes 
 
 
 
 
 
 
 
 
 
 
A version of this chapter is in preparation for submission to Neuropsychological 
Rehabilitation (2014) 
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5.1 Abstract 
BACKGROUND AND PURPOSE: It is unclear whether older adults with type 2 diabetes 
(DM) exhibit impairments in executive function, the set of processes responsible for 
goal-oriented behavior.  We examined executive function in older adults with DM, and 
explored its relationships to gait and functional ability.  METHODS: Forty individuals 
with type 2 diabetes were compared to a matched group of 40 individuals without 
diabetes.  Each subject completed a battery of 10 executive function tests assessing the 
processes of information updating, task shifting, response inhibition, and visuospatial 
and verbal processing and memory.  Self-selected normal and fast walking speed and 
stride length variability were measured using a GaitMat II System, and self-reported 
functional ability assessed via the Late Life Function and Disability Index (LLFDI).  
RESULTS: Subjects with DM performed more poorly on a measure of updating and 
visuospatial function.  No significant differences were observed on measures of shifting, 
inhibition, visuospatial memory, and verbal processing or memory.  Visuospatial 
memory was the only variable associated with gait or functional ability in those with DM.  
However, measures of updating, shifting, inhibition, and visuospatial memory were 
associated with gait and/or functional abilities in the comparison group.  DISCUSSION 
AND CONCLUSIONS: Older adults with DM may exhibit deficits in the executive 
processes responsible for updating and visuospatial processing.  It is also appears that 
executive functions may contribute differently to gait and functional ability in those with 
and without diabetes.  Further research should more clearly examine executive function 
in those with DM, and determine whether executive dysfunction contributes to physical 
deficits, falls, and disability in this high risk patient population. 
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5.2 Introduction 
 A central component of human behavior, executive function refers to the 
collective set of cognitive processes responsible for planning, coordinating, sequencing, 
and monitoring goal-oriented activities (Hull, Martin, Beier, Lane, & Hamilton, 2008). 
Representing a critical link between cognitive and physical function, executive abilities 
are thought to provide an awareness of purpose and ability to process and integrate the 
myriad cognitive, motor, and behavioral demands required to function in a complex and 
dynamic environment (Yogev-Seligmann, Hausdorff, & Giladi, 2008).  Broadly, these 
processes are operationalized in tasks that require, among others, the monitoring and 
updating of incoming information, the division and shifting of attention between tasks, 
the inhibition of automatic responses, and the organization of visuospatial and verbal 
information (Hull et al., 2008; Miyake, Friedman, et al., 2000; Miyake, Friedman, 
Rettinger, Shah, & Hegarty, 2001).    
Such abilities clearly have important implications for rehabilitation and, indeed, 
there are indications that even subtle executive disturbances are powerful predictors of 
functional loss (Cahn-Weiner, Malloy, Boyle, Marran, & Salloway, 2000).  Consistent 
with this, a substantial amount of research has linked executive dysfunction to 
spatiotemporal gait abnormalities (Ble et al., 2005; Hausdorff, Yogev, Springer, Simon, 
& Giladi, 2005; Pettersson, Olsson, & Wahlund, 2007; Sheridan, Solomont, Kowall, & 
Hausdorff, 2003), falls (Shumway-Cook, Brauer, & Woollacott, 2000; Shumway-Cook, 
Woollacott, Kerns, & Baldwin, 1997), and other functional impairments (Kuo, Leveille, 
Yu, & Milberg, 2007; Qiu et al., 2006).    
144 
 
Although deficits in executive function are most commonly associated with 
Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, traumatic brain injury, and 
other overtly neurological disorders, there is also increasing evidence of executive 
dysfunction in older adults with type 2 diabetes.  For example, Yeung et al. (2009) 
reported that both “young-old” (ages 53-70) and “old-old” (ages 71-90) members of this 
population performed significantly worse on measures of attention shifting and response 
inhibition than their peers without diabetes.  Likewise, Qui et al. (2006) observed that 
elderly homebound individuals with diabetes exhibited significant deficits on measures 
of updating, visuospatial function, and attention shifting when compared to a similar 
group without diabetes.  This cross-sectional data appears to be corroborated by 
several longitudinal studies describing small but significant baseline deficits in attention 
and attention shifting in this population, with a nearly two-fold risk of decline in these 
areas at 4- and 6-year follow-ups (Fontbonne, Berr, Ducimetiere, & Alperovitch, 2001; 
Gregg et al., 2000).        
 In contrast to these findings, however, some researchers have reported no 
significant impairments on composite measures of executive function in older adults 
with type 2 diabetes (Ruis et al., 2009; Saczynski et al., 2008).  This raises the 
possibility that, if existant, the executive deficits observed in this population may be 
confined to relatively specific processes, and are thus sensitive to the heterogenous 
methods currently used to assess executive function.  Likewise, although a small 
amount of evidence has linked executive dysfunction to gait abnormalities (Brach, 
Talkowski, Strotmeyer, & Newman, 2008; Paul, Ellis, Leese, McFadyen, & McMurray, 
2009; Roman de Mettelinge et al., 2013) and functional impairments (Kuo et al., 2007; 
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Qiu et al., 2006) in those with diabetes, very little is known about the influence of 
executive function on gait and/or functional ability in this population.      
 In chapter 3, we demonstrated that older adults with type 2 diabetes exhibited 
changes in a specific executive ability, multi-tasking, that may have important clinical 
implications.  However, it remains unclear whether these individuals also suffer from 
deficits in other important dimensions of executive function.  The purpose of this 
investigation was to examine the integrity of the executive processes involved in 
information updating, attention shifting, response inhibition, and visuospatial and verbal 
processing and memory in older adults with type 2 diabetes when compared to their 
peers without diabetes.  A secondary aim was to explore the relationships between 
these executive processes and quantitative gait parameters and self-reported physical 
function and disability in this population.  Our exploratory hypotheses were that subjects 
with diabetes would demonstrate significant impairments in these areas of executive 
function, and that poorer executive performance would be associated with poorer gait 
and functional abilities in these individuals.        
 
5.3 Methods 
5.3.1 Study Design and Sample 
 Institutional approval for this cross-sectional study was granted by the Human 
Subjects Committee of the University of Kansas Medical Center.   
 A total of 40 individuals aged 60 years and older with a medical diagnosis of type 
2 diabetes and 40 similarly aged individuals without diabetes were recruited.  Each 
subject with diabetes (DM) was matched to a comparison subject (CN) in terms of age 
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(± 5 years), sex, highest level of education completed (high school vs. college), and the 
presence or absence of hypertension.  This yielded a total sample of 40 matched pairs.  
Subjects were provided with a $50 stipend upon completing the study.  Exclusion 
criteria included the following:  1) known history of central nervous system pathology, 2) 
musculoskeletal or orthopedic conditions significantly affecting gait and/or balance, 3) 
inability to ambulate without an assistive device, 4) self-reported body mass index of > 
45 kg/m2, 5) uncorrectable visual/auditory deficits or color blindness, 6) wounds on the 
weight bearing surfaces of the feet, 7) less than a high school level of education, and/or 
8) cognitive impairment as evidenced by a score of ≥ 2 on the AD8 Dementia Screening 
Interview or a score of < 26 on the Mini-Mental Status Examination.        
 
5.3.2 Procedures   
 Following telephone screening and the signature of an institutionally-approved 
informed consent form, data regarding age, height, weight, medical comorbidities, 
current medications, and number of falls in the past six months were gathered.  Fasting 
blood glucose measurements were then obtained from each subject (Contour Blood 
Glucose Monitoring System, Bayer, Tarrytown, NY), and glycosylated hemoglobin 
(HbA1c) levels measured for each subject with diabetes via disposable finger-stick kits 
(Metrika A1CNow+, Bayer, Tarrytown, NY).  Potential comparison group subjects 
exhibiting fasting blood glucose levels ≥ 126 mg/dL were excluded from participation 
and referred to a physician for further metabolic evaluation.  A small snack was made 
available to each subject once fasting blood glucose level was established.  All study 
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subjects were tested in a normoglycemic state, defined as a blood glucose level of 
between 80 and 250 mg/dL. 
 After glycemic testing, each subject was administered a series of questionnaires 
assessing symptoms of depression, physical activity level, sleep quality, and functional 
ability.  This was followed by a pseudo-randomized battery of executive measures and 
quantitative analyses of gait speed and variability (measures such as the Rey-Osterrieth 
and Wecshler Logical Memory Tests included immediate and delayed recall 
components, and could not be truly randomized).  All testing was conducted by the 
same research personnel in a quiet laboratory setting to minimize distraction. 
 
5.3.3 Measures 
Executive Function Assessments 
Each subject was administered a battery of executive function assessments 
selected on the basis of neuropsychological research and recommendations (Hull et al., 
2008; Miyake, Emerson, & Friedman, 2000) and expert consultation (J. McDowd).  This 
battery included measures specifically selected to assess each of the following 
executive domains: 
 
Monitoring and Updating of Information (Updating)  
1) The Keep-track Verbal Test was used to assess the ability to update internal 
representations in response to changing external stimuli (Miyake, Friedman, et al., 
2000; Yntema, 1963).  Subjects were first familiarized with a series of 6 index cards, 
each of which contained the title of a semantic category (relatives, metals, distances, 
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countries, colors, and animals), as well as with a series of cards containing 10 words 
from each category.  Before each trial, the subject randomly selected 2 of the 6 
category cards, which remained visible throughout the trial.  They were then shown 
10 randomly ordered cards containing words from each of the 6 categories.  After 
viewing all 10 cards, the subject attempted to recall the last word presented in each 
of the 2 relevant target categories.  Subjects completed 2 practice trials, followed by 
4 blocks of 10 target trials. The number of correct responses on the 40 target trials 
was recorded for data analysis. 
2) The N-back test was also used assess the executive ability of updating (Hull et al., 
2008; Kirchner, 1958).  Subjects were asked to monitor a continuous series of 5 
letters (C, K, N, R, and V) projected onto a 15’’ computer monitor, and to provide a 
yes or no response indicating whether each letter was repeated after an intervening 
letter (e.g. C-K-C = yes, C-K-R = no).  Each viewed letter represented one trial, and 
was displayed for a period of 2.5 seconds before advancing to the next trial.  
Subjects completed 1 practice run of 20 trials, followed by 1 test run of 60 trials, of 
which 15 trials consisted of a repeated letter. The number of correct responses on 
the 60 target trials was recorded for data analysis. 
 
Mental Set and Task Shifting (Shifting)  
1) The Trail Making Test was used to assess the ability to shift attention between 
different task requirements (Homack, Lee, & Riccio, 2005).  In part A of the test 
subjects drew a line connecting series of letters or numbers in order as quickly as 
possible (e.g. A-B-C; 1-2-3 etc.).  In part B of the test subjects drew a line 
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connecting numbers and letters in an alternating fashion (e.g. 1-A-2-B-3-C etc.).  
The percent change in the time required to complete the two conditions was 
calculated, with a higher percent change reflected poorer shifting ability.  
2) The Local-Global Test was also used to assess shifting ability (Miyake et al., 2000; 
Navon, 1977).  Subjects were first familiarized with a series of Navon figures, in 
which a “global” figure (e.g. a large letter H) is comprised of smaller “local” figures 
(e.g. many small letter S’s), and instructed to verbally identify the local letters if the 
figure was red, and the global letter if the figure was blue.  A block of 15 practice 
trials was provided, followed by the random administration of 2 blocks of 30 test 
trials in which the figure colors remained constant across successive trials (e.g. non-
switching trials) and 2 blocks of 30 test trials in which figure colors changed (e.g. 
switching trials).  Incorrect responses were immediately pointed out by the examiner, 
so that error-correction influenced the total time required to complete the trial.  The 
average times required to complete the switching and non-switching trials were used 
to calculate the percent change between the two conditions.  As with the TMT, a 
higher percent change reflected poorer shifting ability. 
 
Response Inhibition (Inhibition) 
1) The Stroop Word Color Test was used to assess the ability to inhibit automatic, 
predominant responses (Miyake, Friedman, et al., 2000; Stroop, 1935).  In the color 
naming condition of the test, subjects were provided with an 8’’x11’’ card containing 
120 blue, red, and green colored X’s arranged in a 20 row by 6 column 
configuration.  Upon beginning the test, subjects moved horizontally across each 
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row, stating aloud the color of as many of the X’s as possible within a 45-second 
period.  In the second, inhibition condition, subjects were presented with an 8’’x11’’ 
card containing an identical 20 by 6 configuration of the words “blue,” “red,” and 
“green” printed in incongruous colors (e.g. the word “green” printed in blue ink).  
Subjects were asked to state aloud the color of as many of the words as quickly as 
possible in a 45-second period.  The percent change in the number of correct 
responses obtained from each condition was calculated, with a higher percent 
change reflecting poorer inhibition ability.  
2) The Hayling Sentence Completion Test was also used to assess inhibition ability 
(Burgess & Shallice, 1996).   In part A of the test, subjects were read a series of 15 
simple sentences with the last word missing, and asked to verbally provide a word 
that would logically complete the sentence as quickly as possible.  For example, the 
sentence “The old house will be torn…” might be completed with the word “down.” In 
part B of the test, subjects were read a second set of 15 similar sentences and 
asked to verbally complete each sentence as quickly as possible with a word that did 
not fit the context of the sentence.  For example, the sentence “The old house will be 
torn…” might be completed with a word such as “peanut.”  Inappropriate responses 
were immediately pointed out by the examiner, so that error-correction influenced 
the total time required to complete the trial, and the amount of time required to 
complete parts A and B were used to calculate a percent change score between the 
two conditions.  As with the Stroop test, a higher percent change reflected poor 
inhibition ability. 
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Visuospatial and Verbal Processing and Memory 
1) The Rey-Osterrieth Complex Figure Test was used to assess visuospatial 
organization and memory (Lezak, Howieson, Loring, Hannay, & Fischer, 2004; Rey 
& Osterrieth, 1993).  Subjects were given a copy of an asymmetrical geometric 
figure and asked to draw the figure as accurately as possible on a blank sheet of 
paper without the use of a straight edge.  Immediately following this copy trial, both 
the figure and the subject’s drawing were removed.  After a delay of 40-60 minutes, 
the subject was provided with a second blank sheet of paper and asked to 
reproduce the figure from memory as accurately as possible.  Both figures were 
scored on a standardized 36-point scoring system according to the accuracy and 
relative position of 18 specified components of the drawing, with a score of 36 
reflecting a nearly identical reproduction of each component. 
2) The Wechsler Logical Memory Test was used to assess the ability to organize and 
recall ideas expressed in story form (Lezak et al., 2004; Wechsler, 1997).  Subjects 
were read a standardized thematic story and asked to immediately recall the story 
using as many of the same words as possible. After a delay of 40-60 minutes, 
subjects were asked to recall the story again in as much detail as possible. Both the 
immediate and delayed recall tests were scored according to a standardized system 
based on the correct recall of 25 specified story units, in which a score of 25 points 
indicated nearly perfect recall. 
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Gait and Functional Assessments 
1) Quantitative analysis of gait was performed using a GaitMat II gait analysis system 
(E.Q., Inc., Chalfont, PA). This system consists of a 4 meter long walkway housing 
38 rows of 256 pressure sensitive switches connected to a computer analysis 
system via a USB interface.  Subjects began walking approximately 2 meters prior to 
stepping onto the GaitMat, and were instructed to continue walking to a point 
approximately 2 meters beyond the GaitMat.  Three trials were conducted at each 
subject’s self-selected “normal” walking speed, followed by three trials in which they 
were instructed to walk “as quickly and safely as possible”.    Subjects wore their 
normal footwear, and were not allowed to utilize an assistive device during gait 
analysis. Gait velocity (in m/s) and stride length variability (expressed as the 
coefficient of variation: [SD/mean]*100) for both normal and fast walking conditions 
were collected and averaged across the 3 trials.   
2) The Late Life Function and Disability Instrument (LLFDI) is a comprehensive 
measure of physical function and disability specifically designed for older adult 
populations (Dubuc, Haley, Ni, Kooyoomjian, & Jette, 2004).  The physical function 
component of the measure consists of 32 items evaluating self-reported difficulty in 
physical activities involving upper extremity function, lower extremity function, and 
advanced lower extremity function (e.g. running, etc.).  Subjects were asked “How 
much difficulty do you have doing [a particular activity] without the help of someone 
else and without the use of an assistive device?” and responded “none”, “a little”, 
“some”, “quite a lot”, or “cannot do.”  Overall physical functioning was scored on a 
scale of 0-100, with higher scores reflecting higher levels of function.   
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A further 16 items assessed the frequency of participation in and ability to 
perform major life tasks.  Subjects were asked how often they performed a particular 
task, and rated the extent to which they felt limited in that task with responses of “not 
at all,” “a little,” “somewhat,” “a lot,” and “completely”.  Frequency and disability 
indices were also scored on scales of 0-100, with higher scores reflecting a higher 
frequency of participation and a lower degree of disability.   
 
General Assessments 
1) The Mini-Mental Status Examination (MMSE) was used to assess global cognitive 
function (Folstein, Folstein, & McHugh, 1975).  This 30-point instrument broadly 
reflects orientation, memory, concentration, and praxis, and is sensitive to moderate 
to severe cognitive impairment.  As it seemed unlikely that severe cognitive deficits 
would be due exclusively to diabetes, any individual scoring < 26 on this measure 
was excluded from study participation. 
2) Beck’s Depression Inventory-II (BDI) was used to assess self-reported symptoms of 
depression (Beck, Steer, & Brown, 1996).  This measure is scored on a 21-item, 63-
point scale, with scores of 19 or less indicating minimal symptoms of depression, 20-
28 moderate symptoms, and ≥ 29 severe symptoms. 
3) The Rapid Assessment of Physical Activity (RAPA) was used to assess physical 
activity level (Topolski et al., 2006).  Subjects responded “yes or no” to 7 questions 
describing their usual level of participation in physical activity.  Scores categorized 
subjects into one of 5 levels of activity: 1=sedentary, 2=under-active, 3=regular 
under-active (light activity), 4-5=regular under-active, and 6-7=regular active. 
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4) The Pittsburgh Sleep Quality Index (PSQI) was used to assess sleep quality and 
disturbance (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989).  This questionnaire 
consists of 19 self-rated questions comprising 7 component scores, each rated on a 
Likert scale of 0 (no difficulty) to 3 (severe difficulty).  Addition of the 7 component 
scores generated a global score of 0-21.  A global score of 5 or greater indicated 
poor sleep quality. 
 
5.3.4 Statistical Analysis   
Data analysis was conducted using SPSS 16.0 for Windows (Chicago, IL).  Normally 
distributed data are presented as mean ± standard deviation, and non-normal data as 
median (range).  In many cases, test results were analyzed as the percent change in 
performance between a baseline condition and a more challenging experimental 
condition.  This was calculated via the following formula:     
|Percent Change| = (Baseline performance – Experimental performance)      x 100 
                                                      Baseline performance 
By convention, a positive percent change reflected a decline in task performance from 
baseline, whereas a negative percent change represented an improvement in 
performance from baseline.   
Data distribution and variance was examined via scatter and Q-Q plots, 
assessed with Kolmogrov-Smirnov and Shapiro-Wilk tests, and descriptive statistics 
were calculated for all variables.  As subjects in the diabetes and comparison groups 
were paired, mean between- and within-group differences and 95% confidence intervals 
were examined via 2-tailed, 1 sample paired t-tests.  The Wilcoxon signed rank test 
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assessed differences in non-normal data.  Pearson-product-moment and Spearman’s 
rank sum correlations explored the relationships between variables for normally and 
non-normally distributed data, respectively.  Type I error rate was set at 0.05. 
 
5.4 Results 
5.4.1 Sample Characteristics 
 Table 5.1 provides the general characteristics of the groups.  Forty individuals 
with type 2 diabetes (65% female) and 40 paired individuals without diabetes (65% 
female) consented and participated in this study.  Seventy-eight percent of the 
individuals in both groups were college educated, with the same percentage reporting a 
diagnosis of hypertension.   
Those with diabetes exhibited higher fasting blood glucose (p<0.001), were more 
obese (p<0.001), and had more symptoms of depression (p=0.04) than comparison 
subjects.  Longer term glycemic control in the diabetes group was also impaired 
(median HbA1c 6.8%, range 5.4 – 11.2).  Eight subjects (20%) in this group reported a 
diagnosis of peripheral neuropathy, 2 (5%) mild retinopathy, and 1 (2.5%) nephropathy.  
A total of 6 subjects (15%) in the diabetes group and 2 in the comparison group (5%) 
reported having 2 or more falls in the preceding six months.  No significant between-
group differences were observed in age, global cognitive function, and self-reported 
physical activity level or sleep quality.          
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Table 5.1:  Sample Characteristics 
 Diabetes  
(n=40) 
Comparison 
(n=40) 
P-value 95% CI 
Age  
(years) 
 
72.9 ± 8.3 72.9 ± 7.7 0.90 -1.1 – 1.2 
BMI  
(kg/m2) 
 
31.1 ± 4.7 26.6 ± 4.4 < 0.001 2.6 – 6.4 
FBG  
(mg/dL) 
 
134.3 ± 45.9 92.3 ± 14.1 < 0.001 25.0 – 51.3 
MMSE  
(score out of 30) 
 
28.7 ± 1.2 29.2 ± 1.0 0.07 -1.0 – 0.04 
BDI   
(score out of 63)  
 
4.5 ( 0 – 28) 3.0 (0 – 31) 0.04
a 
-0.4 – 5.2 
RAPA 
(score out of 10) 
 
4.9 ± 1.3 4.8 ± 1.5 0.63 -0.6 – 0.9 
PSQI 
(score out of 21) 
 
5.0 (1 – 12) 4.0 (1 – 18) 0.34
a 
-1.2 – 2.0 
Table 5.1: Abbreviations: BMI, body mass index; FBG, fasting blood glucose; MMSE, Mini-Mental Status 
Examination; BDI, Beck’s Depression Inventory-II; RAPA, Rapid Assessment of Physical Activity; PSQI, 
Pittsburgh Sleep Quality Index. 
a
Wilcoxon Signed Rank Test.   
 
5.4.2 Executive Assessments 
 Table 5.2 provides the results of the executive function testing battery.  Broadly, 
the data provides limited support for our exploratory hypothesis of executive dysfunction 
in older adults with type 2 diabetes.  Specifically, subjects with diabetes performed 
worse on one measure of updating, the Keep Track Test (p=0.014), but not on the 
second, the N-back Test (p=0.80).  Those with diabetes also performed more poorly on 
the copy trial of the Rey Osterrieth Complex Figure Test of visuospatial processing 
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(p=0.007), but not on the recall trial of visuospatial memory (p=0.16).  No significant 
differences were observed on either measure of shifting (Trail Making, p=0.96; Local 
Global, p=0.32) or inhibition (Stroop, p=0.97; Hayling, p=0.38).  Likewise, no differences 
were observed on either the immediate (p=0.177) or delayed recall (p=0.123) trials of 
the Wechsler Logical Memory Test. 
 
5.4.3 Quantitative Gait Analysis 
  Due to equipment malfunction, quantitative gait data could not be obtained for 3 
individuals, and data for the corresponding pair-matched subjects were also removed 
from the analysis.  Results from the 37 remaining pairs are provided in Table 5.3 and 
illustrated in Chapter 3, Figures 3.5 A and B.  Individuals with diabetes ambulated more 
slowly than comparison subjects at a self-selected “normal” walking pace (p=0.03), but 
with a similar degree of stride length variability (p=0.77).  When instructed to walk “as 
quickly and safely as possible”, those with diabetes demonstrated both slower speeds 
(p=0.001) and greater stride variability than comparison subjects (p=0.02). 
 
5.4.4 Late Life Function and Disability Index 
 Results of the Late Life Function and Disability Index are also reported in Table 
5.3.  The groups scored similarly on the frequency (p=0.42) and disability (p=0.06) 
scales of the LLFDI; however those with diabetes scored significantly lower on the 
physical function component (p<0.001).      
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Table 5.2:  Executive Assessments 
 Diabetes  
(n=40) 
Comparison 
(n=40) 
P-
value 
95% CI 
Updating 
     Keep Track   
     (score out of 40) 
 
 
36  
(20-40) 
 
38  
(27-40) 
 
0.01a 
 
-4.2 – -0.6 
     N-Back 
     (score out of 60) 
 
43.8 ± 9.6 43.2 ± 9.3 0.80 -4.1 – 5.2 
Shifting 
     Trail Making 
     (% change) 
 
 
19.9 ± 36.9 
 
19.5 ± 35.7 
 
0.96 
 
-16.3 –17.1 
     Local-Global  
     (% change) 
 
37.8  
(8.5 – 62.8) 
38.8  
(12.8 – 133.8) 
0.59a -13.6 – 4.5 
Inhibition 
     Stroop Word Color  
     (% change)  
 
 
42.8 ± 15.0 
 
42.9 ± 11.3 
 
0.97 
 
-7.1 – 6.8 
     Hayling Sentence    
     Completion 
     (% change) 
 
146.8 ± 83.3 129.8 ± 73.7 0.38 -21.6 – 55.7 
Visuospatial Organization 
     Rey Osterrieth, Copy  
     (score out of 36) 
 
28.5 ± 4.2 
 
30.8 ± 2.6 
 
0.007 
 
-3.9 – -0.7 
     
     Rey Osterrieth, Recall  
     (score out of 36) 
 
 
10.4 ± 5.1 
 
12.4 ± 5.9 
 
0.16 
 
-4.9 – 0.8 
Verbal Logical Memory 
     Wechsler Logical Memory, 
     Immediate (score out of 25)  
 
     Wechsler Logical Memory,  
     Delayed (score out of 25)  
 
 
13  
(3 – 19) 
 
10.1 ± 4.2 
 
14  
(3 – 25) 
 
11.8 ± 5.2 
 
0.18a 
 
 
0.12 
 
-2.9 – 0.7 
 
 
-3.8 – 0.5 
Table 5.3: Data are presented as mean ± SD or median (range).  
a
Wilcoxon Signed Rank Test 
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Table 5.3:  Gait and Functional Assessments 
 Diabetes  
(n=37) 
Comparison 
(n=37) 
P-value 95% CI 
Gait Velocity 
     Normal Walking 
 
1.0 ± 0.2 
 
1.1 ± 0.2 
 
0.03 
 
-0.2 – -0.01 
     (m/s)   
    
     Fast Walking 
     (m/s) 
   
 
 
1.4 ± 0.4 
 
 
1.6 ± 0.3 
 
 
0.001 
 
 
-0.3 – -0.1 
Gait Variability 
     Normal Walking 
     (%) 
 
     Fast Walking 
     (%) 
 
4.3  
(0.1 – 16.1) 
 
5.4 ± 2.5 
 
4.6 
(2.4 – 15.9) 
 
4.0 ± 1.7 
 
0.77a 
 
 
0.02 
 
-1.1 – 1.9 
 
 
0.3 – 2.5    
     
Late Life Function and 
Disability 
     Frequency  
     (score out of 100)  
 
 
 
56.3 ± 6.5 
 
 
58.6 ± 9.7 
 
 
0.42 
 
 
-4.5 – 1.9  
     Disability 
     (score out of 100) 
 
     Physical Function 
     (score out of 100) 
79.7 ± 14.2 
 
 
60.6 ± 9.6 
85.3 ± 13.8 
 
 
67.5 ± 8.2 
0.06 
 
 
< 0.001 
-11.3 – 0.1 
 
 
-10.1 – -3.7 
Table 5.3: Data are presented as mean ± SD or median (range).  
a
Wilcoxon Signed Rank Test 
 
5.4.5 Relationships between Executive Functions and Gait and Functional Ability 
 Bivariate correlations explored the relationships between executive function 
assessments and quantitative measures of gait and self-reported functional ability 
separately in the diabetes and comparison groups.  Tables 5.4 A and B provide the 
results of these analyses.  Largely in contrast to our secondary hypothesis, the Rey 
Osterrieth Complex Figure recall was the only executive factor significantly related to 
any gait or functional measure in subjects with diabetes.  Specifically, poorer 
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performance on this measure was associated with a lower reported frequency of 
participation on the LLFDI (r=0.32, p=0.04).   
In comparison subjects, however, we observed a number of significant 
relationships between executive function and gait and functional ability.  In this group, 
poorer performance on both of our updating measures, the Keep Track and N-back 
tests, was associated with slower walking speed under both normal (r=0.34, p=0.03 and 
r=0.34, p=0.03, respectively) and fast walking conditions (r=0.37, p=0.02 and r=0.43, 
p=0.006, respectively).  Moreover, poorer performance on shifting (Trail Making; r=-
0.33, p=0.04) and inhibition measures (Stroop; p=-0.35, r=0.03) were also related to 
slower normal walking speed, whereas poorer visuospatial memory was associated with 
a greater walking speed under fast walking conditions (Rey Osterrieth recall; r=-0.53, 
p=0.001).  Finally, poorer performance on an inhibition measure, the Hayling Sentence 
Completion Test, was associated with a lower frequency of participation on the LLFDI 
(r=-0.32, p=0.04) in this group. 
 
5.5 Discussion 
 Although exploratory, the results of this investigation provide insight into the 
integrity of executive functions in older adults with type 2 diabetes, and their possible 
contributions, or lack thereof, to gait and functional abilities.  Specifically, we observed 
that these individuals performed worse on some measures of updating and visuospatial 
organization.  Further, our data appear to suggest that executive functions may 
contribute differentially to gait in those with and without diabetes. 
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Broadly, the results of our executive assessment are consistent with those of 
Yeung et al. (2009), Qui et al. (2006), and others (Fontbonne et al., 2001; Gregg et al., 
2000) in describing features of executive dysfunction in older adults with diabetes.  
However, the widely varied testing methods used to assess executive function in these 
studies provide limited context by which to interpret our results.  Perhaps most 
analogous to our investigation, Yeung and colleagues (2009) administered a cognitive 
battery including a total of 4 executive measures, 3 of which, the Hayling, Stroop, and 
Trail Making Tests1, were also administered in our study.  This group reported that 
subjects with diabetes exhibited significant impairments of 14% and 12% on the Hayling 
and Trail Making Tests, respectively, with non-significant decrements of 16% on the 
Stroop Test and 13% on a measure of visuospatial processing, the Brixton Spatial 
Anticipation Test.  In contrast, we observed a significant deficit of 7% on visuospatial 
processing measure, the copy trial of the Rey Osterrieth Complex Figure, a similar but 
non-significant decrement of 12% on the Hayling Test, and virtually no differences (≤ 
2%) on the Stroop and Trail Making Tests.  In addition, we noted a significant deficit of 
7% on the Keep Track Test, a measure of updating not represented in Yeung et al.’s 
testing battery.   
Although a common problem in research examining executive function, the 
factors that underlie these discrepancies are not entirely clear.  It is certainly plausible 
that sample characteristics such as age, sex, education, and other demographic and/or 
comorbid factors could account for these conflicting results.  Equally relevant is the fact 
                                                          
1
 These authors administered a slightly different version of the Trail Making Test, the Colored Trails Test, in which 
subjects were asked to shift between numbers and colors, rather than numbers and letters.  This may reduce the 
influence of verbal function and/or language on the test. 
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that executive function itself currently lacks a clear definition and conceptual framework 
upon which to develop and standardize tests and measures.  As a result, executive 
measures are often posited to measure ambiguous and poorly operationalized qualities 
such as “planning” or “reasoning,” and many are highly sensitive to task impurity – a 
phenomenon in which deficits in non-executive processes such as language or vision 
impair test performance despite intact executive function (Miyake, Emerson, et al., 
2000). 
In addition to the fact that our diabetes and comparison groups were pair-
matched in terms of age, sex, education, and the presence or absence of hypertension, 
a major strength of the present study is the use of a battery of relatively well-defined 
executive measures supported by current neuropsychological research (Hull et al., 
2008; Miyake, Emerson, et al., 2000).  Further, our use of multiple measures to assess 
each executive process provides additional context by which to interpret our results.  
For example, we observed that subjects with diabetes performed more poorly on one 
measure of updating, the Keep Track Test.  However, there were no significant 
differences on a second updating measure, the N-back Test.  It is possible that this 
reflects a difference in the difficulty of the two tasks, as many subjects found the Keep 
Track Test to be relatively simple, while most reported that the N-back was extremely 
challenging.  This may have resulted in a floor effect on the N-back Test, and thus 
masked potential executive differences.  It may also, or instead, suggest that those with 
diabetes did not demonstrate gross impairments in updating ability but, rather, exhibited 
deficits in a task specific aspect of the Keep Track Test.  Unfortunately, it is unclear 
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whether this deficit involves features of the executive process of updating or a separate, 
non-executive process. 
It is also difficult to interpret the results of our correlational analyses, which 
revealed few relationships between executive performance and gait or functional ability 
in those with diabetes, but a number of significant associations between these factors in 
comparison subjects.  Particularly notable was the fact that both of our measures of 
updating, the Keep Track and N-back Tests, were significantly associated with self-
selected normal walking speed in this group, and these relationships strengthened 
during fast walking.  This may indicate that some executive functions, and particularly 
the ability to process incoming information from the environment, normally play a role in 
mediating gait speed.  The lack of such relationships in subjects with diabetes could 
reflect a pathological dissociation of executive function and gait, and it is possible that 
this contributed to the significantly slower normal and fast walking speeds we observed 
in these individuals. 
Although consistent with our data, this speculation is hypothetical and must be 
considered in the context of several factors that limit interpretation of our findings.  First 
among these is the relatively small size of our sample, which does not fully power our 
multiple comparisons.  Due to the exploratory nature of this investigation, we did not 
correct for the multiple comparisons and correlations we performed.  This limits the 
conclusions that can be drawn from this data; however our findings clearly provide 
interesting directions for future research.  Another limitation is the possibility that some 
subjects included in our study may have suffered from undiagnosed mild cognitive 
impairment or early Alzheimer’s disease.  This is of particular concern because type 2 
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diabetes is associated with an increased risk for these conditions (Kuusisto et al., 1997; 
Luchsinger et al., 2007; Ott et al., 1999).  We attempted to control for this confounding 
factor by screening all potential subjects with the AD8 Dementia Screening Interview 
(Galvin et al., 2005) prior to inclusion in the study, and excluding any individual scoring 
less than 26 on the Mini-Mental Status Examination.  However, it is certainly possible 
that these measures may have failed to identify some individuals with these conditions. 
Finally, our data do not establish a direct link between executive function and the 
gait impairments, functional deficits, and disability commonly observed in older adults 
with type 2 diabetes.  However, our findings are broadly consistent with those of other 
researchers who have identified links between executive function and self-care, disease 
management, and physical function in these individuals.  Future efforts should be 
directed towards identifying the anatomical and physiological mechanisms underlying 
diabetes-related cognitive changes, and more closely examining the characteristics and 
functional consequences of cognitive and executive dysfunction in this highly vulnerable 
and dramatically expanding population. 
 
5.6 Conclusions 
 This investigation provides evidence that older adults with type 2 diabetes may 
exhibit changes in the executive abilities required to update and monitor incoming 
information and process visuospatial information.  Our data also suggest that these and 
other executive functions may contribute differently to gait and functional ability in those 
with and without diabetes.  Further research should attempt to more clearly examine 
cognitive and executive function in those with diabetes, and determine the extent to 
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which cognitive impairments contribute to physical deficits, falls, and disability in this 
high risk population. 
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Chapter 6 
 
 
 
 
 
 
 
 
 
Multi-tasking, Executive Function, and Functional Abilities in Older Adults with 
Type 2 Diabetes Mellitus 
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6.1 Summary of Findings 
 Collectively, the data presented here represent one of the most detailed cross-
sectional examinations of multi-tasking and executive function conducted in older adults 
with type 2 diabetes.  Our results indicate that these individuals demonstrate significant 
changes in gait stability when required to multi-task while walking.  In addition, they may 
exhibit changes in the executive abilities responsible for updating and processing 
incoming stimuli and visuospatial information.  The influence of these and other 
executive processes on gait and functional abilities remains unclear, but appears to 
differ between those with and without diabetes.  This chapter summarizes the findings 
of our investigations and describes our preliminary exploration of possible mechanisms 
underlying diabetes-related executive impairments.  The chapter concludes with the 
potential clinical implications, limitations, and future directions that can be drawn from 
this body of work. 
 
Chapter 2: Pilot Study of Multi-tasking and Executive Function in Adults with Diabetic 
Peripheral Neuropathy 
 Laying the groundwork for our primary investigation, this pilot study employed a 
small battery of common measures of executive function to compare executive 
performance between a convenience sample of individuals with diabetic peripheral 
neuropathy (DPN) and a similar group of individuals without diabetes or neuropathy.  
We also explored the relationships between executive and neuropsychological function, 
signs and symptoms of peripheral neuropathy, and a measure of functional ability in 
those with DPN.   
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 We found that this relatively young sample of adults with DPN performed poorly 
on verbal and visuospatial measures of executive function, as well as a measure of 
multi-tasking, the Cognitive Timed Up and Go Test.  In addition, we observed significant 
relationships between overall cognitive function and depression, and found that both 
factors were associated with performance on the traditional, single-task Timed Up and 
Go Test. 
 
Chapter 3:  Multi-tasking in Older Adults with Type 2 Diabetes 
 Despite previous research demonstrating that multi-tasking while walking impairs 
gait speed and kinematics in individuals with diabetes irrespective of the presence of 
peripheral neuropathy, we were unable to identify a comprehensive assessment of 
multi-tasking abilities in older adults with diabetes.  The purpose of this portion of our 
investigation, and the primary overall aim of this body of work, was to provide such an 
assessment.   
Our results indicated that older adults with type 2 diabetes did not exhibit broad, 
global impairments in multi-tasking abilities.  However, they did perform more poorly 
than their peers without diabetes when required to multi-task while walking and, 
alarmingly, appeared to sacrifice gait stability in order to preserve other task demands.  
Interestingly, although multi-tasking ability demonstrated little relationship with 
measures of gait, physical function, or disability in either group, factors such as 
depression, physical activity, and sleep quality were significantly associated with these 
measures in both groups – most notably in those with diabetes.              
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Chapter 4:  The Contribution of Multi-tasking to Gait and Functional Ability in Older 
Adults with Type 2 Diabetes 
 The secondary aim of our investigation was to more closely examine the 
contribution of multi-tasking abilities to single-task gait and physical function and 
disability in those with diabetes.  In order to do this, we constructed a series of 
regression equations in which multi-tasking, along with variables such as age, glycemic 
control, and depression, were used to predict gait velocity and variability during normal 
and fast walking, as well as self-reported levels of physical function and disability.  In 
addition, based on the unexpected strength of the correlations we had observed 
between these criterion variables and depression, physical activity, and sleep quality, 
we also developed a series of post-hoc regression models specifically assessing these 
relationships. 
 This analysis revealed that multi-tasking ability exerted little influence on our 
measures of single-task gait, physical function, or disability.  In contrast, we did observe 
a number of significant relationships between these criterion variables and depression, 
physical activity, and sleep quality.  Overall, our findings suggest that multi-tasking 
abilities may play a limited role in the performance of routine, every day activities in 
higher functioning older adults with diabetes.  However, they also highlight the 
importance of appropriately identifying and treating other modifiable but easily 
overlooked comorbidities common in this population.                    
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Chapter 5:  The Integrity of Other Executive Functions in Older Adults with Type 2 
Diabetes 
 The final aim of our investigation was to examine whether older adults with type 2 
diabetes exhibited impairments in the executive functions responsible for updating 
incoming information from the environment, shifting attention between different tasks, 
inhibiting predominant responses, and visuospatial and verbal processing and 
organization.  Additionally, because few previous studies had attempted to examine 
how such executive functions might relate to gait and/or functional abilities, we explored 
the relationships between our executive assessments and measures of gait speed and 
variability and self-reported physical function and disability.               
 We found that subjects with diabetes demonstrated poorer performance on 
specific measures of updating and visuospatial function when compared to a non-
diabetic group of individuals pair-matched for age, sex, education, and hypertensive 
status.  Interestingly, we observed few relationships between executive and gait or 
functional measures in those with diabetes, but a number of significant associations 
between these variables in those without diabetes.  Although difficult to interpret, our 
findings appear to suggest that older adults with diabetes demonstrate features of 
executive dysfunction, and may provide the first evidence that executive functions 
contribute differently to gait and function in those with and without diabetes.           
 
6.2 Possible Mechanisms of Executive Dysfunction in Diabetes 
 As discussed in Chapter 1, there is now a good deal of evidence that the diabetic 
disease process can result in neuroanatomical changes in brain areas associated with 
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executive function (Kodl & Seaquist, 2008).  The mechanisms by which these changes 
occur remain a matter of considerable speculation; however there is growing interest in 
the relationships between type 2 diabetes and Alzheimer’s disease, and the role that 
insulin resistance may play in the cognitive deficits associated with both.  In particular, 
several investigations have indicated that insulin is associated with one of the key 
pathological markers of Alzheimer’s disease, amyloid beta (Aβ) (De Felice et al., 2009; 
Kulstad et al., 2006; Zhao et al., 2008).  This relationship may occur directly, as insulin 
itself appears to promote Aβ transport and deposition (Gasparini et al., 2001), and/or 
indirectly via increased cortisol production, which has also been linked to both Aβ 
deposition and cognitive dysfunction (Toledo et al., 2012). 
 In order to establish a framework for future studies investigating the pathological 
mechanisms that may link type 2 diabetes and Alzheimer’s disease, we analyzed 
fasting plasma levels of insulin, cortisol, and Aβ in a subset of individuals from both our 
diabetes and comparison groups.  The preliminary results of this exploratory 
investigation are described below. 
 
6.2.1 Sample and Methods 
 A total of 20 subjects from the diabetes group and 20 subjects from the 
comparison group volunteered to submit a blood sample for analysis.  As this study 
component was optional, we did not attempt to pair-match diabetes and comparison 
group subjects.  Each subject completed the primary study measures of executive 
function, gait, and functional ability, as detailed in Chapters 3 and 5.  After signing a 
separate institutionally approved informed consent form, those who volunteered for the 
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optional study component fasted for a minimum of 8 hours before presenting to the 
University of Kansas Medical Center’s Clinical and Translational Science Unit, where a 
peripheral venous blood draw was conducted.   
 Following collection, blood specimens were centrifuged at 1000G, flash frozen, 
and stored at -80 degrees C.  On the day of testing, all samples were thawed 
simultaneously at room temperature and 300µL of plasma aliquoted from each sample 
for analysis of insulin, cortisol, and the amyloid peptide Aβ-42.  Enzyme-linked 
immunosorbent assays (ELISAs) for each analyte were performed by the Disease 
Model and Assessment Core at the University of Kansas Medical Center.  A single 
average value of each analyte was calculated from each specimen via duplicate 
determination, and quality controlled through examination of internally referenced 
control values, standard curve graphs, and replicate variability. 
 Fasting insulin and blood glucose levels for each subject were used to determine 
insulin resistance via the Homeostatic Model of Assessment – Insulin Resistance 
(HOMA-IR).  This was calculated as described by Matthews et al. (1985):   
 
Fasting Glucose Level (mg/dL) x Fasting Insulin Level (µIU/mL) 
4051 
 
6.2.2 Statistical Analysis 
Non-parametric methods were employed for all analyses due to the exploratory 
nature of the investigation.  Mann-Whitney U Tests assessed between-group 
                                                          
1
 This conversion factor applies to samples measured in mg/dL (glucose) and µUI/mL (insulin).  A conversion factor 
of 22.5 is used for samples measured in mmol/L (glucose) and mU/L (insulin). 
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differences, while Spearman’s rank sum correlations assessed relationships between 
variables.  Type I error rate was set at 0.05. 
 
6.2.3. Results 
Sample Characteristics and General Assessments 
 Table 6.1 provides the general characteristics of the groups.  Twenty subjects 
with diabetes (60% female) and 20 subjects without diabetes (60% female) consented 
to this sub-study.  No significant differences in age were observed between the two 
groups (p=0.27).  Those with diabetes were more obese (p=0.001) and demonstrated 
impaired fasting blood glucose levels (p<0.001) when compared to those without 
diabetes.  No between-group differences were observed on the Mini-Mental Status 
Examination (MMSE; p=0.13), Beck’s Depression Inventory (BDI; p=0.11), Rapid 
Assessment of Physical Activity (RAPA; p=0.12), or Pittsburgh Sleep Quality Index 
(PSQI; p=0.32).         
 
Insulin Resistance, Cortisol, and Amyloid Beta-42 Assessments 
 Table 6.2 provides the results of ELISA analyses of insulin resistance, cortisol, 
and Aβ-42 levels.  Subjects with diabetes exhibited a higher level of insulin resistance 
when compared to those without (median HOMA-IR 2.7 vs. 1.5 units, p=0.02).  No 
significant differences were observed in either cortisol (p=0.14) or Aβ-42 levels 
(p=0.26).    
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Table 6.1:  Sample Characteristics 
 Diabetes  
(n=20) 
Control  
(n=20) 
P-value 
Age  
(years) 
 
70 (60 – 85) 68 (61 – 83) 0.27 
BMI  
(kg/m2) 
 
33.3 (23.7 – 39.5) 26.85 (20.2 – 40.6) 0.001 
FBG  
(mg/dL) 
 
113.5 (89.0 – 282.0) 90.5 (68.0 – 119.0) < 0.001 
MMSE  
(score out of 30) 
 
29.0 (27.0 – 30.0)  29.0 (28.0 – 30.0) 0.13 
BDI   
(score out of 63)  
 
4.0 ( 1.0 – 17.0) 3.0 (0 – 31) 0.11 
RAPA 
(score out of 10) 
 
5.5 (3.0 – 7.0) 6.0 (3.0 – 7.0) 0.63 
PSQI 
(score out of 21) 
 
5.5 (2 – 12) 4.0 (1 – 18) 0.34 
Table 6.2:  Data are median (range). Abbreviations:  BMI: body mass index; FBG: fasting blood glucose; 
MMSE: Mini-mental Status Examination; BDI: Beck’s Depression Inventory - II; RAPA: Rapid Assessment 
of Physical Activity; PSQI: Pittsburgh Sleep Quality Instrument 
 
Table 6.2: Insulin Resistance, Cortisol, and Amyloid Beta-42 Levels  
 Diabetes  
(n=20) 
Comparison  
(n=20) 
P-value 
Insulin Resistance (HOMA-IR) 2.7 (0.6 – 7.3) 1.5 (0.5 – 3.0) 0.02 
Cortisol (ng/mL) 66.7 (31.3 – 413.3) 56.5 (18.2 – 104.3) 0.14 
Amyloid Beta-42 (pg/mL) 27.3 (2.5 – 171.5) 18.7 (3.6 – 145.4) 0.26 
Table 6.2: Data are median (range). HOMA-IR: Homeostatic Model of Assessment – Insulin Resistance 
 
Executive Assessments 
 Results of the executive testing battery are not presented, as between-group 
comparisons of executive performance were not a primary focus of the investigation.  
183 
 
Those with diabetes performed more poorly on the copy version of the Rey Osterrieth 
Complex Figure Test (median score 28.5 vs. 31.5 points, p=0.01), a measure of 
visuospatial function.  No significant differences were observed in measures of multi-
tasking (p=0.11), updating (p=0.23 and 0.24), task shifting (p=0.40 and 0.73), inhibition 
(p=0.42 and 0.75), or verbal logical memory (p=0.07). 
 
Relationships between Insulin Resistance, Cortisol, Amyloid Beta-42, and Executive 
Function 
 Correlations between insulin resistance, cortisol, Aβ-42, and executive function 
measures are provided in Table 6.3.  Higher cortisol levels were associated with higher 
Aβ-42 levels in the diabetes group (r=0.45, p=0.04); however this relationship was not 
observed in the comparison group (Fig.1).  Insulin resistance was not significantly 
associated with cortisol or Aβ-42 levels in either group. 
 In subjects with diabetes, higher cortisol levels were associated with poorer 
performance on a measure of updating (N-back; r=-0.58, p=0.008) and task shifting 
(Trail Making; r=0.49, 0.03), while higher Aβ-42 levels were associated with poorer 
performance on an updating measure (Keep Track; r=-0.45, p=0.04) and two measures 
of task shifting (Trail Making; r=0.59, p=0.006 and Local-Global; r=0.59, p=0.01).  
Insulin resistance was not significantly correlated with any measure of executive 
function in either group, and cortisol and Aβ-42 were not correlated with any executive 
measures in the comparison group. 
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In addition, our findings are broadly in line with a recent study by Toledo et al. (2012), 
which found a significant association between elevated plasma cortisol levels and 
increased brain amyloid deposition in a group comprised of 22 cognitively normal 
individuals, 21 individuals with Alzheimer’s disease, and 56 individuals with mild 
cognitive impairment.  
 While the specific mechanisms underlying the interaction of cortisol and amyloid 
are unresolved, and their impact on cognitive function remains unclear, there is 
evidence that both type 2 diabetes and Alzheimer’s disease are associated with 
upregulation of the hypothalamic-pituitary-adrenal axis (Csernansky et al., 2006; Lee et 
al., 1999; Tojo et al., 1996).  The resulting hypercortisolemia may initiate a damaging 
cascade that increases amyloid and tau production and causes structural injury (Kodl & 
Seaquist, 2008; Tortosa-Martinez & Clow, 2012).  However, it is also possible that these 
neuropathological features precede the elevation of cortisol levels, and that hyper-
cortisolemia is instead a consequence of this neurological damage (Tortosa-Martinez & 
Clow, 2012).      
Also unclear is the role of insulin and insulin resistance, which were not 
correlated to cortisol, amyloid, or executive function in either of our groups.  These 
findings are somewhat in contrast to investigations that have observed a differential role 
for insulin in mediating Aβ metabolism and cognitive function in those with and without 
Alzheimer’s disease (Burns et al., 2012), and found that insulin resistance was 
associated with cognitive impairment and an increased risk of cognitive decline in non-
demented individuals (Yaffe et al., 2004).   
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One factor that may help explain these conflicting results is the use of oral anti-
glycemic medications and/or exogenous insulin agents by subjects in our diabetes 
group, which may have altered or masked relationships between insulin and the other 
variables we examined.  A second factor is the possible role of apolipoprotein E (APOE) 
genotype, which we were unable to assess.  The ε4 allele of APOE is a known risk 
factor for Alzheimer’s disease (Saunders et al., 1993), and the presence or absence of 
the ε4 allele may mediate relationships between insulin, Aβ, and cognitive function 
(Morris & Burns, 2012).   
 
6.2.5. Preliminary Conclusions 
 This exploratory investigation provides interesting evidence that peripheral levels 
of cortisol and Aβ-42 are differentially related to each other and to aspects of executive 
function in older adults with type 2 diabetes when compared to those without diabetes.  
Future studies will be needed to clarify the mechanisms by which these factors interact 
in health and disease, and to more clearly determine their effects on cognitive and 
executive function.  Further research will also be necessary to determine the role of 
inflammatory factors, reactive oxygen species, advanced glycation end products, 
endothelial dysfunction, and other factors not examined in the current study.  Described 
in detail in Chapter 1, these variables may also contribute to the pathophysiology of 
cognitive dysfunction in both diabetes and Alzheimer’s disease.        
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6.3 Clinical Implications 
Type 2 diabetes is projected to affect a staggering 592 million individuals by the 
year 2035 – fully 10% of the world’s population (International Diabetes Federation [IDF], 
2013).  In the United States alone, the disease is expected to affect nearly 30 million 
individuals and cost well in excess of $336 billion (Huang, Basu, O'Grady, & Capretta, 
2009).  Among the most common diseases of aging, diabetes is associated with a 
devastating array of neurological complications affecting both the peripheral and central 
nervous systems. 
With one in every three older adults in the United States expected to suffer from 
diabetes by the year 2050 (Centers for Disease Control and Prevention [CDC], 2011), 
there is an increasingly urgent need to understand its physiological and functional 
consequences so that effective preventive and treatment strategies can be established 
and administered.  From a rehabilitation standpoint, this includes interventions aimed at 
reducing falls, functional and disability, improving gait and functional ability, and 
increasing physical activity and fitness.  The body of work presented here has a number 
of clinical implications related to such rehabilitation strategies. 
A major factor implicit in the development of this project is the disproportionately 
high prevalence, risk, and severity of falls experienced by older adults with diabetes 
(Crews, Yalla, Fleischer, & Wu, 2013).  One of the primary findings of our investigation 
is that these individuals exhibit deficits in the ability to multi-task while walking, such that 
gait stability is sacrificed in favor of less critical task demands.  Although further 
research will be necessary to establish whether this does indeed contribute to falls and 
functional deficits in this population, it does not seem unreasonable to suspect that this 
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may be the case.  If so, our results are encouraging in that the deficits we observed 
appeared to reflect poor task prioritization, as opposed to gross or global impairments in 
the ability to multi-task per se.  This may suggest that relatively simple educational and 
multi-task training interventions could reorient at-risk individuals to more appropriate 
task prioritization strategies that minimize risk and maximize safety.   
Although not directly addressed in our investigation, our findings also have 
implications for the clinical application of single- and multi-task training interventions.  It 
is not uncommon for rehabilitation service providers to administer gait and functional 
training under controlled, single-task conditions with the assumption that improvements 
will carry over to more complex, environmentally realistic conditions.  Likewise, it is 
often assumed that training conducted under dual-task conditions should translate to 
improvements in the single-task performance of either or both tasks.  In fact, this may 
not be the case.  Our results indicate that the resources required to multi-task are 
relatively distinct from those required for ambulation under single-task conditions, and 
emphasize that clinicians should carefully consider task and context specificity when 
designing and implementing rehabilitation interventions.       
 Finally, our results challenge the commonly held belief that gait abnormalities, 
falls, and functional deficits in those with diabetes are primarily the result of neuropathic 
and/or musculoskeletal impairments.  This body of work argues, instead, that these 
deficits are multi-factorial and influenced by a diverse array of variables.  In particular, 
we found that some aspects of executive function appeared to be differentially related to 
gait and physical function in older adults with and without diabetes, and observed 
surprisingly strong relationships between depression, physical activity, sleep quality, 
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and gait and function.  These findings stress the importance of appropriately managing 
common and modifiable but easily overlooked comorbidities in older adults with 
diabetes, and emphasize that clinicians must be prepared to identify and address both 
physical and neuropsychological dysfunction in these individuals.       
 
6.4. Limitations 
Subject Characteristics and Sample Size 
We attempted to control for several important confounding variables by pair-
matching each subject with diabetes to a comparison subject in terms of age (± 5 
years), sex, level of education, and the presence or absence of diagnosed hyper-
tension.  However, it is inherently difficult to perfectly match non-discrete variables such 
as education and blood pressure, and we acknowledge that this may have affected our 
sample.  Likewise, we did not control for intelligence (e.g. IQ), race/ethnicity, or 
socioeconomic status, and these factors may also have influenced our results.  Despite 
these limitations, the characteristics of our groups were largely homogenous and do not 
appear to have differed greatly from those of other investigations.    
An additional limitation of our sample was its relatively modest size of 40 subjects 
per group.  This sample size adequately powers the primary aim of our investigation, 
the comparison of multi-tasking abilities described in Chapter 3.  However, it does limit 
the conclusions that can be drawn from the regression analyses undertaken in Chapter 
4 and the multiple comparisons of executive function conducted in Chapter 5.  As such, 
caution should be exercised in interpreting these results until they can be validated by 
future research.        
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Comorbidities and Medications 
 Although we collected data on the comorbid conditions and medication usage of 
each subject, we did not exclude participants on the basis this information unless it was 
deemed to result in significant cognitive or physical impairment.  As a result, our sample 
included individuals with osteoarthritis, joint arthroplasty, mild visual impairments, 
peripheral neuropathy, and other such conditions.  Moreover, our subjects took a variety 
of medication for many different purposes, including the use of anti-diabetic agents and 
exogenous insulin by many subjects in our diabetes group.  Given the widespread 
prevalence of diabetic complications (CDC, 2011) and the fact that the population of 
interest in our investigation was individuals 60 years old and older, it would likely be 
impossible to recruit a sample that controlled for all of these variables.   
In order to limit the influence of confounding variables, each subject completed a 
telephone screening interview designed to elicit information about their current cognitive 
and functional status, as well as any impairments in vision, gait, and/or balance.  
However, we did not formally assess visual acuity, somatosensory or proprioceptive 
function, or other such factors.  Nor is it possible to say with certainty that our cognitive 
screening procedures successfully excluded all individuals with mild cognitive 
impairment or pre-clinical Alzheimer’s disease.  Clearly, it is important that our findings 
be interpreted in the context of such potential limitations.     
 
Executive Assessments 
 As described in Chapter 1, executive function is notoriously difficult to define and 
assess.  This is especially true because executive function is dependent upon and 
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expressed by non-executive processes such as language, vision, and/or memory, and 
broadly considered to be responsible for complex and poorly operationalized abilities 
such as planning, reasoning, and organization.  At present there is no standardized 
methodology for assessing executive function; however neuropsychological researchers 
have recommended that 1) executive terms and processes be clearly defined, 2) 
assessment measures carefully selected to target these executive functions, and 3) 
multiple, simple measures used to assess each executive function (Miyake, Emerson, & 
Friedman, 2000; Suchy, 2009). 
 Perhaps more than any previous examination of executive function in individuals 
with diabetes, our executive assessment battery reflects these guidelines.  Chapter 1 
provides a detailed explanation of the executive processes we selected, as well as 
research underlying the measures we employed to assess these processes.  Despite 
this, it is possible that differences in task difficulty or other characteristics may have 
influenced our results, or that they may have been affected by differences in non-
executive processes.  Further research will be needed in order to fully characterize 
executive abilities in older adults with diabetes.           
        
6.5 Future Directions 
 This body of work addresses several key areas of interest with regard to multi-
tasking and executive function in older adults with type 2 diabetes, and the relationships 
between these variables to gait and functional ability in this population.  However, a 
number of questions remain unanswered.  For example, although we speculate that the 
changes in Walking and Remembering Task performance we observed in our subjects 
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with diabetes could contribute to the elevated fall risk known to occur in this population, 
there are currently no established links between such changes and fall risk.  Future 
research will be needed to determine fall risk cut-offs on this measure, as well as 
whether specific task prioritization strategies may be associated with differing levels of 
fall risk.  
In much the same way, it will be important to examine how different populations 
utilize task difficulty and contextual information to assign task priority during multi-
tasking.  For example, one might expect that individuals suffering from somatosensory 
and proprioceptive deficits due to peripheral neuropathy would adopt compensatory 
strategies that maximize safety when required to multi-task while walking.  However, we 
observed that subjects with peripheral neuropathy, like their counterparts without 
neuropathy, actually sacrificed gait stability in order to preserve less important task 
demands.  Future research should use task combinations of varying type, complexity, 
and environmental validity to better understand how attention is allocated during multi-
tasking, and explain why and under what circumstances safety may be sacrificed.  
 Equally important will be research examining the effectiveness of intervention 
strategies designed to improve multi-tasking function and/or task prioritization strategies 
during multi-tasking.  Consistent with our findings suggesting little relationship between 
multi-tasking ability and single-task gait speed and stability, other investigations have 
reported that dual-task training interventions have little effect on single-task function, 
and vice versa (Schwenk, Zieschang, Oster, & Hauer, 2010; Silsupadol, Lugade, et al., 
2009; Silsupadol, Shumway-Cook, et al., 2009; You et al., 2009).  Future studies should 
continue to more clearly define the respective roles of single- and dual-task training so 
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that rehabilitation intervention strategies can be more effectively designed and 
administered.         
 In addition to the issues related to multi-tasking discussed above, a number of 
questions remain regarding the relationship between diabetes and executive and 
cognitive functions.  This investigation elicited evidence of potential impairment in 
several executive processes, specifically those related to updating and visuospatial 
function.  However, it is possible that these impairments arose due to specific task 
characteristics and/or task impurity, rather than true executive dysfunction.  Moreover, it 
remains unclear why we observed such substantial differences in the contributions of 
executive functions to gait and function in those with and without diabetes.  Future 
research using similarly designed executive testing batteries will be needed to more 
clearly characterize executive function in those with diabetes, as well as to determine 
how it contributes to gait and functional ability in older adults both with and without 
diabetes.        
 Finally, as discussed previously in this chapter, there is a great deal of interest in 
the mechanisms that may underlie cognitive dysfunction in type 2 diabetes, and their 
relationships to the pathology of Alzheimer’s disease.   Consistent with many other 
investigations, the exploratory data presented here appear to suggest shared 
pathological mechanisms between the two diseases.  However, further research will be 
necessary to specifically determine how insulin and insulin resistance, dysglycemia, 
cortisol, vascular disease, genetics, and other factors interact and relate to 
neurocognitive impairments in diabetes and Alzheimer’s disease.    
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6.6 Conclusions 
 This body of work provides evidence that older adults with type 2 diabetes exhibit 
deficits in the ability to multi-task while walking that result in decreased gait stability.  In 
addition, these individuals may demonstrate impairments in other areas of executive 
function, particularly those responsible for updating incoming information and 
processing visuospatial stimuli.  There seems to be little relationship between multi-
tasking or other executive functions and single-task gait or self-reported physical 
function and disability in individuals with diabetes; however these factors and others 
such as depression, physical activity, and sleep quality appear to influence gait and 
function differently in those with and without diabetes.  Overall, our findings emphasize 
the diverse factors that may contribute to functional abilities in this high-risk population, 
and highlight the need for further research investigating the physiological, psychological, 
and functional consequences of type 2 diabetes. 
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